Настройки

Укажите год
-

Небесная энциклопедия

Космические корабли и станции, автоматические КА и методы их проектирования, бортовые комплексы управления, системы и средства жизнеобеспечения, особенности технологии производства ракетно-космических систем

Подробнее
-

Мониторинг СМИ

Мониторинг СМИ и социальных сетей. Сканирование интернета, новостных сайтов, специализированных контентных площадок на базе мессенджеров. Гибкие настройки фильтров и первоначальных источников.

Подробнее

Форма поиска

Поддерживает ввод нескольких поисковых фраз (по одной на строку). При поиске обеспечивает поддержку морфологии русского и английского языка
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Укажите год
Укажите год

Применить Всего найдено 6077. Отображено 100.
16-02-2012 дата публикации

Pullulan replacements for films and coatings

Номер: US20120037039A1
Автор: Marceliano B. Nieto
Принадлежит: TIC Gums Inc

This disclosure relates generally to materials configured to replace pullulan and pullulan functionalities and their use in applications such as edible films, coatings, breath or flavor strips, tablet coatings, gel caps, tobacco products, films for cheese or spice flavor delivery, films as barriers in food products, and non food products including industrial, personal care and pharmaceutical products. In addition, the materials and methods disclosed herein are configured for use in similar products that do not incorporate pullulan but would benefit from pullulan-like properties and functionalities.

Подробнее
03-05-2012 дата публикации

Immuno-compatible hydrogel system

Номер: US20120107394A1
Принадлежит: Individual

An immuno-compatible hydrogel system is provided that is resistant to protein binding. The hydrogel system is prepared by contacting a hydrogel solution with a cross-linking agent to form a gel, exposing the gel to an aqueous solution comprising a first polyelectrolyte to form a polyelectrolyte-coated hydrogel, exposing the polyelectrolyte-coated hydrogel to a second polyelectrolyte to form a crosslinked matrix and exposing the matrix to conditions which eliminates, or at least reduces, protein binding sites on the matrix.

Подробнее
17-05-2012 дата публикации

Porous composite biomaterials and production method of the same

Номер: US20120122219A1
Принадлежит: Individual

The invention discloses a porous composite biomaterial comprising of poly(γ-glutamic acid)-g-chondroitin sulfate (γ-PGA-g-CS) copolymer and poly(ε-caprolactone). The composite biomaterial provides a three-dimensional microenviroment for using as a scaffold for tissue engineering and for supporting the attachment and proliferation of cells. The invention also discloses a method of producing a porous composite biomaterial.

Подробнее
26-07-2012 дата публикации

Macroporous Microcarrier Specific to Liver Cell, Preparation Method and Use Thereof

Номер: US20120190113A1
Принадлежит: Individual

The present invention provides a macroporous microcarrier specific to hepatocytes using silk fibroin and galactosylated chitosan as main raw material, a preparation method thereof, and application for hepatocyte culture under the culture condition of microgravity rotation. The macroporous microcarrier s a sphere prepared from silk fibroin and galactosylated chitosan under the effect of crosslinker, wherein based on the total weight of the sphere, the content of silk fibroin is 50-80 wt % and the content of galactosylated chitosan is 15-40 wt %. The diameter of the microcarrier is 200-500 μm, and the aperture of the microcarrier is 40-80 μm. Compared with normal solid scaffold material, the microcarrier provided by the present invention has larger surface area/volume ratio and, a sinus gap structure extremely similar with in-vivo liver sinus structure, therefore it is more conducive to adhering of the hepatocytes on the scaffold material, contacting between cells, transporting oxygen and nutrient components and excreting metabolic products.

Подробнее
26-07-2012 дата публикации

Formulations and methods for solid chitosan-containing blends

Номер: US20120190757A1
Принадлежит: Halosource Inc

Chitosan-containing blends and methods of dissolving and using chitosan are disclosed. A blend includes a solid acid or a solid agent that generates a proton in situ in the presence of water mixed together with a dry solid chitosan, and may optionally contain other components. The blends are in a dry, free-flowing, particulate form. Methods of dissolving a blend typically comprise adding a quantity of the blend to a low volume of water and mixing until the chitosan and solid acid or solid agent are dissolved and then further diluting this mixture by the addition of water, or used as-is. Devices containing the blends are also described along with methods of using the devices, such as for controlled release of solubilized chitosan in a body of water, such as a stream, containing impurities (e.g., particles, sediment, or suspended matter or dissolved substances) to cause flocculation or precipitation of such impurities.

Подробнее
26-07-2012 дата публикации

Methods for Steam Flash Extraction of Pectin

Номер: US20120190831A1
Принадлежит: CP KELCO APS

Methods are provided for high temperature and short time extraction of pectins from pectin-containing plant materials. Generally described, the method includes mixing the pectin-containing plant material and an acidic aqueous medium to form a mixture; heating the mixture (optionally under pressure) to a target temperature by steam injection; maintaining the mixture under pressure at the target temperature for a time up to about 5 minutes; and flashing the mixture into a flash tank at a pressure from about 0.5 to about 1.2 bar to extract pectin from the pectin-containing plant material.

Подробнее
01-11-2012 дата публикации

Metal-polysaccharide conjugates: compositions, synthesis and methods for cancer therapy

Номер: US20120277409A1

The current disclosure, in one embodiment, includes a polysaccharide conjugate. This conjugate has a polysaccharide and at least one liner covalently bound to the polysaccharide. The conjugate also has at least one metal conjugated by said linker. According to another embodiment, the disclosure provides a method of synthesizing a polysaccharide conjugate by covalently bonding a linker to a polysaccharide to obtain an intermediate and by conjugating said intermediate to a metal to form a polysaccharide conjugate. This conjugate has a higher relaxivity, so it is suitable to be used as a contrast medium for hybrid camera.

Подробнее
13-12-2012 дата публикации

Modified pectins, compositions and methods related thereto

Номер: US20120315309A1
Автор: James Rolke, Mark Staples
Принадлежит: La Jolla Pharmaceutical Co

The present invention provides compositions of modified pectin and methods for preparing and using them.

Подробнее
13-12-2012 дата публикации

Biodegradable composition comprising polymers of natural origin and aliphatic-aromatic copolyesters

Номер: US20120316257A1
Автор: Catia Bastioli
Принадлежит: Novamont SpA

The present invention relates to a biodegradable composition comprising at least one polymer of natural origin and at least one aliphatic-aromatic copolyester obtained starting from mixtures comprising aliphatic diols, polyfunctional aromatic acids, and at least two aliphatic dicarboxylic acids, at least one of which is long chain. Said composition combines improved biodegradability, excellent mechanical properties, a high level of industrial processability, limited environmental impact as well as stability of physical properties under the influence of environmental factors.

Подробнее
14-02-2013 дата публикации

Phase separated composite

Номер: US20130041044A1

A composite is disclosed. The composite comprises a first conjugate of a polymer and a first phenol-containing moiety, and a second conjugate of a gelatin or collagen and a second phenol-containing moiety, wherein the polymer is selected so that the first conjugate is less cell-adhesive than the second conjugate, at least one of the first and second conjugates is crosslinked to form a matrix, and the composite comprises discrete regions that are rich in one of said first and second conjugates. A method of forming such composite is also disclosed. The method comprises mixing precursors for the first and second conjugates in a solution for forming said composite, and dispersing a catalyst in the solution to catalyze crosslinking of at least one of the first and second conjugates to form the matrix. The composite may be used to grow cells.

Подробнее
21-03-2013 дата публикации

Aliphatic-aromatic copolyesters and their mixtures

Номер: US20130071588A1
Принадлежит: Novamont SpA

This invention relates to an aliphatic-aromatic copolyester characterised in that it has appreciable workability properties even when mixed with other polymers, appreciable toughness and high values for ultimate tensile strength and elastic modulus. This invention also relates to mixtures of the said copolyester with other polymers.

Подробнее
09-05-2013 дата публикации

Methods of making hyaluronic acid/collagen compositions

Номер: US20130116411A1
Принадлежит: Allergan Inc

Hyaluronic acid and collagen may be crosslinked in aqueous solution as described herein. The crosslinked macromolecular matrices obtained in this process may be used as a hydrogel for implants and fillers for human aesthetic and therapeutic products.

Подробнее
30-05-2013 дата публикации

NOVEL POLYMER AND PROCESS FOR PRODUCING THE SAME

Номер: US20130137850A1
Принадлежит: JNC CORPORATION

An objective of the invention is to provide an excellent biomaterial having a good operability and a high safety; the solution is a polymer having one or more peptide units represented by formula (1) as described below and one or more saccharide residues derived from polysaccharides: 2. The polymer according to claim 1 , comprising a triple helical structure.3. The polymer according to claim 1 , wherein a weight ratio of the peptide unit(s) to the saccharide residue(s) is in the range of 95/5 to 50/50.4. The polymer according to claim 1 , wherein the polysaccharides are selected from hyaluronic acid claim 1 , carboxylmethyl cellulose claim 1 , chondroitin sulfate claim 1 , dextran claim 1 , heparin and dermatan sulfate.5. The polymer according to claim 1 , further having one or more amino acid residues or one or more peptide units claim 1 , in addition to the peptide unit(s).6. The polymer according to claim 5 , wherein the further amino acid residue(s) is/are a glycine residue(s) or a lysine residue(s).7. The polymer according to claim 1 , wherein the peptide unit and the saccharide residue derived from the polysaccharides are bonded between a carboxyl group thereof and an amino group thereof.8. A process for producing the polymer according to claim 1 , comprising a step for allowing a condensation reaction between a peptide oligomer including the peptide unit represented by formula (1) and the polysaccharides. This is a Non-Provisional application, which claims priority to Japanese Patent Application No. 2011-261127, filed on Nov. 30, 2011; the contents of which are all herein incorporated by this reference in their entireties. All publications, patents, patent applications, databases and other references cited in this application, all related applications referenced herein, and all references cited therein, are incorporated by reference in their entirety as if restated here in full and as if each individual publication, patent, patent application, database or ...

Подробнее
06-06-2013 дата публикации

COMPLEX OBTAINED FROM HYALURONIC ACID OR A SALT THEREOF AND CHONDROITIN SULPHATE MIXTURES

Номер: US20130143838A1
Принадлежит: QUIMERA INGENIERIA BIOMEDICA, S.L.

The present invention relates to a novel complex, obtainable by mixing hyaluronic acid or a salt thereof and chondroitin sulphate or a salt thereof, and forming an aqueous solution of said mixture, which is further subjected to a drying process. The invention also relates to various compositions and formulations comprising the complex of the invention, process for obtaining said complex and uses thereof. 2. The complex according to claim 1 , wherein the hyaluronic acid or a salt thereof has an average molecular weight greater than 1 claim 1 ,200 claim 1 ,000 Daltons.3. The complex according to claim 1 , wherein the weight ratio of hyaluronic acid or a salt thereof to chondroitin sulphate or a salt thereof is from 1:1 to 1:10.4. The complex according to claim 3 , wherein the weight ratio of hyaluronic acid or a salt thereof to chondroitin sulphate or a salt thereof is 1:1.5. A pharmaceutical composition comprising the complex as defined in to be administered by a route selected from the group consisting of parenteral administration claim 1 , oral administration and topical administration.6. The pharmaceutical composition according to claim 5 , wherein the concentration of the complex to be administered parenterally is equal or greater than 20 mg/mL.7. The pharmaceutical composition according to claim 5 , wherein said composition is administered by intra-articular injection.8. The pharmaceutical composition according to claim 5 , wherein the amount of complex to be administered orally is equal or greater than 220 mg.9. The pharmaceutical composition according to claim 5 , wherein the concentration of the complex to be administered topically is equal or greater than 70 mg/mL.10. A pre-filled syringe for intra-articular application comprising the pharmaceutical composition according to .11. An artificial matrix for intra-articular implantation comprising the pharmaceutical composition according to .12. A pharmaceutical composition according to claim 5 , for use in ...

Подробнее
13-06-2013 дата публикации

SPINNING SOLUTION FOR INDUSTRIAL PRODUCTION OF PURE CHITOSAN FIBER AND THE METHOD FOR FABRICATING THE SAME

Номер: US20130145958A1
Автор: Hu Guangmin, Zhou Jiacun

It is an object of the present invention to provide a spinning solution for industrial production of pure chitosan fiber and the method for fabricating the same. The method comprises the steps of: step (a): screening a flake chitosan raw material and removing impurities; step (b): putting in a dissolving kettle the screened flake chitosan raw material with a weight which is 3%-8% of the total weight of the spinning solution, sealing the dissolving kettle, and evacuating into vacuum; step (c): adding 0.9%-6% acetic acid solution, and soaking at the room temperature for 40-60 minutes; step (d): uniformly stirring at a rate of 26-60 rpm for 7.5-19 hours under a pressure of ≦5000 pa in the dissolving kettle, standing for 1-3 hours, and obtaining a spinning solution. By using this method, it is possible to not only maintain the original state structure of the molecular chain of chitosan, but also fast and uniformly dissolve flake chitosan and the spinning solution fabricated by this method in unit time, so as to meet the requirements in the industrial continuous production. 1. A spinning solution for industrial production of pure chitosan fiber , characterized in that , the used chitosan raw material is flake , and has a deacetylation degree ≧92% and a viscosity ≧1000 mpa·s.2. The spinning solution for industrial production of pure chitosan fiber according to claim 1 , characterized in that claim 1 , the used chitosan raw material has a deacetylation degree ≧95% and a viscosity ≧1500 mpa·s.3. A method for fabricating spinning solution for industrial production of pure chitosan fiber according to characterized in that claim 1 , the method comprises the steps of:step (a): screening a flake chitosan raw material and removing impurities;step (b): putting in a dissolving kettle the screened flake chitosan raw material with a weight which is 3%-8% of the total weight of the spinning solution, sealing the dissolving kettle, and evacuating into vacuum;step (c): adding 0.9%-6% ...

Подробнее
20-06-2013 дата публикации

Treatment of surfactant laden wastewater

Номер: US20130153512A1
Принадлежит: General Electric Co

Clarification of surfactant laden wastewaters of the type commonly encountered in the laundry, dishwashing, textile manufacturing, and metal cleaning and degreasing processes is provided by use of a chitosan/(meth)acrylyloxy alkyl quaternary ammonium salt graft polymer.

Подробнее
08-08-2013 дата публикации

USE OF LIPID CONJUGATES IN THE TREATMENT OF DISEASES

Номер: US20130203979A1
Автор: Yedgar Saul
Принадлежит: YISSUM RESEARCH DEVELOPMENT COMPANY

This invention provides compounds represented by the structure of the general formula (A): 2. The compound of claim 1 , wherein said lipid comprises a linear claim 1 , saturated claim 1 , mono-unsaturated claim 1 , or poly-unsaturated claim 1 , alkyl chain ranging in length from 2 to 30 carbon atoms.3. The compound of claim 2 , wherein said alkyl chain comprises a palmitic acid moiety or a myristic acid moiety.4. The compound of claim 3 , wherein said L-Z forms phosphotidylethanolamine claim 3 , phosphotidylserine claim 3 , phosphotidylinositol claim 3 , phosphotidylcholine or phosphotidylglycerol.5. The compound of claim 1 , wherein L is a phospholipid.6. The compound of claim 1 , wherein L is a sphingolipid.7. The compound of claim 1 , wherein L is a ceramide lipid.8. The compound of claim 1 , wherein L is a glycerolipid.9. The compound of claim 8 , wherein L is a deoxyglycerolipid.10. The compound of claim 1 , wherein Y is nothing.11. The compound of claim 1 , wherein any bond between L claim 1 , Z claim 1 , Y and X is either an amide or an esteric bond.12. The compound of claim 1 , wherein X is selected from the group of molecules consisting of polygeline claim 1 , hydroxyethylstarch claim 1 , dextran claim 1 , aspirin claim 1 , albumin claim 1 , alginate claim 1 , polyaminoacid claim 1 , polyethylene glycol claim 1 , lactobionic acid claim 1 , acetylsalicylate claim 1 , cholesteryl-hemmisuccinate claim 1 , maltose claim 1 , cholic acid claim 1 , polycarboxylated polyethylene glycol claim 1 , carboxymethylcellulose claim 1 , and glutaryl.13. The compound of claim 1 , wherein X is a glycosaminoglycan.14. The compound of claim 13 , wherein X is hyaluronic acid.15. The compound of claim 13 , wherein X is heparin.16. The compound of claim 13 , wherein X is chondroitin.17. The compound of claim 16 , wherein X is chondroitin sulfate18. The compound of claim 1 , wherein n is a number greater than 1. This application is a divisional application of U.S. application Ser. ...

Подробнее
22-08-2013 дата публикации

PARTICLE-COMPRISING POLYETHER ALCOHOLS

Номер: US20130217795A1
Принадлежит: BASF SE

The invention relates to particle-comprising polyether alcohols which can be prepared by in-situ polymerization of olefinically unsaturated monomers in a polyether alcohol, wherein the polymerization is carried out in the presence of at least one compound (A) comprising a polyethersiloxane chain on which at least one polyether chain comprising at least one reactive hydrogen atom and a polyether chain comprising at least one olefinic double bond are present. 1. A particle-comprising polyether alcohol which can be prepared by in-situ polymerization of olefinically unsaturated monomers in a polyether alcohol , wherein the polymerization is carried out in the presence of at least one compound (A) comprising a polysiloxane chain to which at least one polyether chain comprising at least one reactive hydrogen atom and a polyether chain comprising at least one olefinic double bond are bound.4. The particle-comprising polyether alcohol according to any of to , wherein the compounds (A) have from 0.7 to 1 groups C in the molecule.5. The particle-comprising polyether alcohol according to any of to , wherein the compounds (A) have a molecular weight Mn of 8000 to 30 000.6. The particle-comprising polyether alcohol according to any of to , wherein the compounds (A) have from 8 to 25 units A and/or C in the molecule.7. The particle-comprising polyether alcohol according to any of to , wherein between each two units A and/or C there are on average from 2 to 8 units C.8. The particle-comprising polyether alcohol according to any of to having a content of particles of from 35% by weight to 65% by weight , based on the weight of the graft polyol.9. The particle-comprising polyether alcohol according to any of to having a hydroxyl number of 40-260 mg KOH/g.10. The particle-comprising polyether alcohol according to any of to , wherein styrene and/or acrylonitrile are used as olefinically unsaturated monomers.11. A process for preparing the particle-comprising polyether alcohols by in- ...

Подробнее
22-08-2013 дата публикации

METHOD FOR PRODUCING COMPOSITE GEL BY CROSS-LINKING HYALURONIC ACID AND HYDROXYPROPYL METHYLCELLULOSE

Номер: US20130217872A1
Автор: Jian Jun, Li Ruizhi
Принадлежит: BEIJING AIMEIKE BIO-TECH CO., LTD.

A method for covalently cross-linking hyaluronic acid (HA) and hydroxypropyl methylcellulose (HPMC) by a diepoxide crosslinking agent. The method includes the following steps: a) mixing HA and HPMC in water; b) adding an alkali as a catalyst and a diepoxide as a crosslinking agent; c) neutralizing with hydrochloric acid and dehydrating with ethanol and acetone; and d) drying in vacuum and redissolving in water to obtain an HA-HPMC composite gel. 1. A method for producing a composite gel by covalently cross-linking hyaluronic acid (HA) and hydroxypropyl methylcellulose (HPMC) , the method comprising the following steps:a) mixing HA and HPMC in water;b) adding an alkali as a catalyst and a diepoxide as a crosslinking agent;c) neutralizing a resulting system by hydrochloric acid and dehydrating with ethanol and acetone; andd) drying in vacuum and redissolving in water to obtain an HA-HPMC composite gel.2. The method of claim 1 , wherein the crosslinking agent is butanediol diglycidyl ether (BDDE) and/or 1 claim 1 ,2 claim 1 ,7 claim 1 ,8-diepoxyoctane (DEO).3. The method of claim 2 , wherein when using DEO as the crosslinking agent claim 2 , the alkali catalyst is tetrabutyl ammonium hydroxide (TBAH) or trimethyloctyl ammonium hydroxide (TMOAH).4. The method of claim 1 , wherein a mass fraction of HPMC in HA-HPMC system is 1%-50%.5. The method of claim 1 , wherein a mass ratio of HA and HPMC to diepoxide is 1:0.05-3.6. A method for producing a composite gel claim 1 , the method comprising the following steps:a) dissolving HA and HPMC in water;b) adding NaOH as a catalyst, DEO and/or BDDE as a crosslinking agent, reacting for 24-36 h at a temperature of 20-30° C. and a pH of 12-14, a mass ratio of BDDE to HA and HPMC being within a range of 1:100-3:1; andc) neutralizing a resulting system with hydrochloric acid to a pH of 6.5-7.5, electing a subset of particles by an average diameter, washing the subset of dehydrated particles with ethanol and acetone, drying the ...

Подробнее
29-08-2013 дата публикации

EGGSHELL MEMBRANE SOLUBILIZATION METHOD USING ENZYMES

Номер: US20130224830A1
Автор: Tanaka Shun-Ichi
Принадлежит: AMANO ENZYME INC.

The present invention addresses the problem of providing an eggshell membrane solubilization method that is capable of solving the problems associated with carrying out treatment using acids and alkalis, or problems associated with the processing methods of the conventional art that use proteases; in other words, an eggshell membrane solubilization method that is capable of solving at least one of the following problems: (1) the need for pretreatment such as pulverization, sonication or boiling; (2) the need for prolonged treatment; and (3) a low decomposition rate (approximately 20%). Eggshell membranes are efficiently solubilized by using a protease in combination with a reducing agent. 1. An eggshell membrane solubilization method using the combination of a protease and a reducing agent.2. The eggshell membrane solubilization method of claim 1 , which comprises the step of subjecting eggshell membranes to the action of a protease in the presence of a reducing agent.3. The eggshell membrane solubilization method of claim 1 , which comprises the following steps (1) and (2):(1) a step of providing eggshell membranes in a solvent; and(2) a step of adding a reducing agent and a protease to the solvent, and causing reactions by them.4. The eggshell membrane solubilization method of claim 3 , wherein the pH of the reaction solution in the step (2) is from 4.5 to 9.5.5. The eggshell membrane solubilization method of claim 3 , wherein the concentration of the reducing agent is from 5 mM to 1 M.6. The eggshell membrane solubilization method of claim 3 , wherein the reaction in the step (2) is continued until no solid is found.7. The eggshell membrane solubilization method of claim 3 , which further comprises the following step (3):(3) a step of filtering the solution after the step (2), thereby removing solids.8. The eggshell membrane solubilization method of claim 1 , wherein the protease is an alkaline or neutral protease.9. The eggshell membrane solubilization method of ...

Подробнее
05-09-2013 дата публикации

POLYSACCHARIDE DERIVATIVES INCLUDING AN ALKENE UNIT AND THIOL-CLICK CHEMICAL COUPLING REACTION

Номер: US20130231474A1
Принадлежит: UNIVERSITE JOSEPH FOURIER - GRENOBLE 1

The invention relates to polysaccharides grafted with a unit including a carbon-carbon double bond, to polysaccharides grafted with a unit including a carbon-carbon double bond functionalized by a thioether unit, to the methods for preparing said compounds, to the compositions including such compounds and to the materials including such materials or compositions. 127-. (canceled)29. The method according to claim 28 , wherein step a) is carried out in a water/DMF claim 28 , water/DMSO or water/isopropanol mixture.30. The method according to claim 28 , wherein step a) is carried out at a pH between 6 and 11.31. The method according to claim 28 , wherein in step a) the molar graft ratio is modulated by the quantity of anhydride added.32. The method according to claim 28 , wherein the polysaccharide is selected from poly(galacturonate)s claim 28 , heparin and derivatives thereof claim 28 , hyaluronic acid and derivatives thereof claim 28 , chondroitin sulfates claim 28 , pectin and derivatives thereof claim 28 , alginates claim 28 , and neutral polysaccharides such as cellulose claim 28 , dextran claim 28 , pullulan claim 28 , starch claim 28 , maltodextrin and derivatives thereof claim 28 , chitin claim 28 , chitosan and derivatives thereof.34. The polysaccharide according to claim 33 , wherein the molar graft ratio is from 0.5 to (number of free hydroxyl functional groups per polysaccharide repeating unit)×100% per polysaccharide repeating unit.35. The polysaccharide according to claim 33 , wherein said polysaccharide is selected from poly(galacturonate)s claim 33 , heparin and derivatives thereof claim 33 , hyaluronic acid and derivatives thereof claim 33 , chondroitin sulfates claim 33 , pectin and derivatives thereof claim 33 , alginates claim 33 , and neutral polysaccharides such as cellulose claim 33 , dextran claim 33 , pullulan claim 33 , starch claim 33 , maltodextrin and derivatives thereof claim 33 , chitin claim 33 , chitosan and derivatives thereof.38. The ...

Подробнее
26-09-2013 дата публикации

MODIFIED PECTINS, COMPOSITIONS AND METHODS RELATED THERETO

Номер: US20130251765A1
Автор: Rolke James, Staples Mark
Принадлежит: LA JOLLA PHARMACEUTICAL COMPANY

The present invention provides compositions of modified pectin and methods for preparing and using them. 1. A liquid composition comprising colloidal particles of a purified modified pectin or a purified , deesterified , and partially depolymerized modified pectin , wherein the particles are less than 1 micron in diameter and the composition is substantially free of modified pectins having molecular weights below 25 kD.2. The composition of claim 1 , wherein the modified pectin material or deesterified and partially depolymerized modified pectin has an average molecular weight from 50-200 kD.3. The composition of claim 2 , wherein the modified pectin material or deesterified and partially depolymerized modified pectin has an average molecular weight from 80-150 kD.4. The method of claim 3 , wherein the modified pectin material or deesterified and partially depolymerized modified pectin has an average molecular weight from 80-100 kD.5. The composition of claim 1 , wherein the composition is an aqueous solution.6. The composition of claim 5 , wherein the solution contains at least 0.5% by weight of the modified pectin material or deesterified and partially depolymerized modified pectin.7. The composition of claim 6 , wherein the solution contains at least 5% by weight of the modified pectin material or deesterified and partially depolymerized modified pectin.8. The composition of claim 1 , wherein the composition is a colloidal suspension.9. The composition of claim 1 , wherein the colloidal particles are less than 0.20 μm in diameter.10. The composition of claim 1 , wherein the composition comprises a modified pectin material.11. The composition of claim 1 , wherein the composition comprises a deesterified and partially depolymerized modified pectin.12. The composition of claim 1 , wherein the modified pectin material or deesterified and partially depolymerized modified pectin inhibits cancer proliferation with an ICless than 200 μg/mL.13. The composition of claim 12 ...

Подробнее
26-09-2013 дата публикации

TOY PUTTY MATERIAL COMPOSITIONS

Номер: US20130253103A1
Автор: WIJERAMA Roshan
Принадлежит:

A putty material primarily used as a toy which is solid and capable of flowing for forming, preferably by manual manipulation, onto various pleasing shapes. This putty material is used primarily by children as an amusement device. The putty material is formed from a homogeneous mixture of primarily water, polyvinyl alcohol, gum, polyethylene terephthalate (PET) and a small amount of borax wherein the ratio by weight of borax to polyvinyl alcohol is preferably in the range of between 1:12 to 1:22. The toy modeling composition can be formed opaque or translucent and can be dyed, particularly when clear, to create various overall artistic effects, and glitter can be applied on the paste to create unusual aesthetic effects, particularly when using white glitter. Coloration can be applied to the materials with translucent ink or with a marker. 1. A children's activities kit for forming a moldable putty composition comprising the following components:(a1) an aqueous borax solution and (a2) an alcohol, wherein the ratio of the alcohol to water is in the range of 1:7 to 1:3 by weight;(b) 2% to less than 5% by weight of xanthan gum; and(c) a colorant.2. The composition of claim 1 , wherein the alcohol comprises a polyvinyl alcohol.3. The composition of claim 1 , wherein the alcohol further comprises propanediol.4. The composition of claim 1 , wherein component (c) is separately disposed from at least one of components (a1) and (a2).5. A method for providing a children's activities kit for forming a moldable putty comprising:(i) providing the following components;(a1) an aqueous borax solution and (a2) an alcohol, wherein the ratio of the alcohol to water is in the range of 1:7 to 1:3 by weight;(bi) 2% to less than 5% by weight of xanthan gum; and(c) a colorant;(ii) combining the components of step (i) to form a moldable putty composition.6. The method of claim 5 , further comprising (iii) manually manipulating the putty composition to a desired retained shape.7. The method ...

Подробнее
10-10-2013 дата публикации

COSMETIC

Номер: US20130267478A1
Автор: KAMEI Masanao
Принадлежит: SHIN-ETSU CHEMICAL CO., LTD.

There is disclosed a cosmetic comprises a sugar compound obtained by reacting a hydroxyl group of a saccharide, an isocyanate group-containing organopolysiloxane represented by the following general formula (1), and an isocyanate group-containing organic compound represented by the following general formula (2). 2. The cosmetic according to claim 1 , wherein the sugar compound is reacted with the isocyanate group-containing organopolysiloxane and the isocyanate group-containing organic compound claim 1 , with the molar ratio being in the range of 0.03 to 0.7 per mole of a hydroxyl group of the saccharide.3. The cosmetic according to claim 1 , wherein the saccharide is a pullulan or a cellulose.4. The cosmetic according to claim 2 , wherein the saccharide is a pullulan or a cellulose.5. The cosmetic according to claim 1 , wherein “n” represents an integer of 3 claim 1 , and R claim 1 , R claim 1 , Rand Rrepresent a methyl group in the general formula (1).6. The cosmetic according to claim 2 , wherein “n” represents an integer of 3 claim 2 , and R claim 2 , R claim 2 , Rand Rrepresent a methyl group in the general formula (1).7. The cosmetic according to claim 3 , wherein “n” represents an integer of 3 claim 3 , and R claim 3 , R claim 3 , Rand Rrepresent a methyl group in the general formula (1).8. The cosmetic according to claim 4 , wherein “n” represents an integer of 3 claim 4 , and R claim 4 , R claim 4 , Rand Rrepresent a methyl group in the general formula (1).9. The cosmetic according to claim 1 , wherein Rrepresents an alkyl group having 3 to 30 carbon atoms in the general formula (2).10. The cosmetic according to claim 2 , wherein Rrepresents an alkyl group having 3 to 30 carbon atoms in the general formula (2).11. The cosmetic according to claim 3 , wherein Rrepresents an alkyl group having 3 to 30 carbon atoms in the general formula (2).12. The cosmetic according to claim 4 , wherein Rrepresents an alkyl group having 3 to 30 carbon atoms in the general ...

Подробнее
17-10-2013 дата публикации

METHOD FOR MAKING A POLYSACCHARIDE DIALDEHYDE HAVING HIGH PURITY

Номер: US20130274225A1
Автор: ADELMAN DOUGLAS J.
Принадлежит: Actamax Surgical Materials, LLC

A method for making polysaccharide dialdehydes is disclosed, which uses a combination of precipitation and separation steps to purify the polysaccharide dialdehyde formed by oxidation of a polysaccharide with periodate. The method is simple, rapid, and provides a polysaccharide dialdehyde having very low levels of iodine-containing species and a low ash content. The polysaccharide dialdehyde is particularly suitable for preparing hydrogel adhesives for medical applications. 1. A method for making a polysaccharide dialdehyde comprising the steps of:a) reacting a polysaccharide with at least one periodate salt at a temperature above about 10° C. to produce a product comprising said polysaccharide dialdehyde, iodate in the form of at least one iodate salt, and optionally periodate in the form of at least one unreacted periodate salt;b) optionally cooling the product of step (a) to a crystallization temperature below about 5° C. and maintaining the product at the crystallization temperature for a time sufficient to form a precipitate comprising at least one periodate salt, and a first supernatant fluid,c) optionally separating at least a portion of the precipitate from the first supernatant fluid;d) adding a source of at least one cation, which is capable of precipitating at least a portion of the iodate, to the product of (a) or the first supernatant fluid of (b) or (c) thereby forming a second precipitate comprising said at least one cation and iodate, and a second supernatant fluid that comprises the polysaccharide dialdehyde;e) separating at least a portion of the second precipitate from the second supernatant fluid;f) adding at least one iodide salt to the second supernatant fluid thereby forming a mixture comprising the polysaccharide dialdehyde and molecular iodine;g) optionally filtering the mixture to obtain a filtrate;h) adding the mixture of (f) or the filtrate of (g) to a solvent selected from the group consisting of acetone, methanol, isopropanol, ethanol, ...

Подробнее
24-10-2013 дата публикации

COMPOSITIONS COMPRISING A COMBINATION OF AT LEAST ONE COLORANT AND AT LEAST ONE POLYSACCHARIDE

Номер: US20130281548A1
Автор: Jin Zhijin, Shi Jingang

Dispersible colorants that include a combination of a colorant and a polysaccharide are provided, wherein the weight ratio of total colorant to total polysaccharide is in the range of 5000:1 to 1:5000. In one aspect, the colorant is a synthetic or natural colorant. In one aspect, polysaccharide is interpreted very broadly and provides a colored precipitate upon the combination of the colorant with the polysaccharide. 1. A dispersible colorant comprising a combination of a colorant and a polysaccharide , wherein the weight ratio of total colorant to total polysaccharide is in the range of 5000:1 to 1:5000.2. The dispersible colorant according to claim 1 , wherein the polysaccharide is cellulose claim 1 , a cellulose derivative or a cross-linked carboxymethylcellulose.3. The dispersible colorant according to claim 1 , wherein the colorant is a natural colorant.4. The dispersible colorant according to claim 1 , wherein the colorant is a natural edible colorant.5. The dispersible colorant according to claim 1 , wherein the colorant is safflower yellow claim 1 , sweet potato red claim 1 , anthoblue claim 1 , sodium copper chlorophyllin claim 1 , gardenia blue claim 1 , carminic acid claim 1 , elderberry claim 1 , red radish claim 1 , beet root red claim 1 , melanin claim 1 , aronia and mixtures thereof.6. The dispersible colorant according to claim 2 , wherein the colorant is safflower yellow claim 2 , sweet potato red claim 2 , anthoblue claim 2 , sodium copper chlorophyllin claim 2 , gardenia blue claim 2 , carminic acid claim 2 , elderberry claim 2 , red radish claim 2 , beet root red claim 2 , melanin claim 2 , aronia and mixtures thereof.7. The disperse colorant according to claim 1 , wherein the colorant is curcumin claim 1 , paprika red claim 1 , lutein claim 1 , J-carotene claim 1 , lycopene and mixtures thereof.8. The disperse colorant according to claim 2 , wherein the colorant is curcumin claim 2 , paprika red claim 2 , lutein claim 2 , β-carotene claim 2 , ...

Подробнее
14-11-2013 дата публикации

Differential Functionalization of Polymers with Amino-Oxy Reagents for Diagnostic Assays

Номер: US20130302877A1
Автор: Lees Andrew
Принадлежит:

This invention relates to a method of conveniently functionalizing the reducing end of a carbohydrate polymer. The method also allows for the length of the polymer to be differentially functionalized. The invention provides a method for preparing polymers with a different functional groups or functionality on the sides than on the reducing end. An advantage of the method of the invention is that the procedures are simpler, preferably requiring less time, fewer steps, reduced temperatures and less harsh chemical components than conventional procedures for differential modification, with the further advantage that the reactions can be carried out in aqueous media. 1. A method of differentially functionalizing a polymer comprising:functionalizing a first moiety of the polymer with a functional reagent such that the polymer contains at least one functional group;functionalizing a second moiety of the polymer containing the at least one functional group by reaction with an amino-oxy reagent to form at least one different functional group.2. The method of claim 1 , wherein the first moiety is the polymer chain of a polysaccharide claim 1 , an oligosaccharide claim 1 , a carbohydrate or a carbohydrate-containing molecule.3. The method of claim 1 , wherein the at least one functional group is an amine claim 1 , a carboxyl claim 1 , a thiol claim 1 , or an amino-oxy group.4. The method of claim 1 , wherein the at least one functional group is a single functional group.5. The method of claim 4 , wherein the single functional group is an amine claim 4 , a carboxyl claim 4 , a thiol or an amino-oxy group.6. The method of claim 1 , wherein the first moiety is a dextran polymer.7. The method of claim 1 , wherein the second moiety is the reducing end of a polymer chain claim 1 , a polysaccharide claim 1 , an oligosaccharide claim 1 , a carbohydrate or a carbohydrate containing molecule.8. The method of claim 1 , wherein the at least one different functional group is an amine claim ...

Подробнее
21-11-2013 дата публикации

HYALURONAN FIBRES, METHOD OF PREPARATION THEREOF AND USE THEREOF

Номер: US20130309494A1
Принадлежит: CONTIPRO BIOTECH S.R.O.

The invention relates to the method of preparation of hyaluronic acid-based fibres, where first the spinning solution of hyaluronic acid and/or a metal compound thereof, optionally containing a metal salt or a hyaluronic acid compound and metal ions, is prepared, then the spinning solution is introduced into the coagulation bath comprising an acid, an alcohol and not more than 10% wt. of water, and optionally a metal salt, resulting in forming a fibre which is preferably left in the coagulation bath and/or is drawn, then the fibre is washed with alcohol and dried. After washing of the fibre, metal ions may be introduced in the fibre by means of the metalization bath. Further, the invention relates to the fibres based on hyaluronic acid and/or a metal compound thereof, having the fibre (monofilament) diameter 4 μm to 1 mm, linear weight 0.1 to 30 g/1000 m (0.1 to 30 tex), tensile strength 0.5 to 3 cN·dtexand loop strength 20 to 80% of the tensile strength. The invention also relates to a silk tow that contains 2 to 50 primary fibres. Moreover, the invention relates to the use of the fibres for the production of woven and non-swoven fabrics. 1. A method of preparation of fibres based on hyaluronic acid and/or a metal compound thereof characterized by that a spinning aqueous solution containing hyaluronic acid and/or a metal compound thereof is prepared which is subsequently spun in a coagulation bath containing an alcohol and an acid , then the fibre is washed and after washing , the fibre is dried.2. The method according to claim 1 , characterized by that after spinning in the coagulation bath claim 1 , at least one of the steps selected from the group comprising maturation of the fibre in the coagulation bath for 1 second to 48 hours and drawing of the fibre at the drawing ratio within the range of 1.1 to 7 is performed.3. The method according to any of the preceding claims claim 1 , characterized by that the spinning solution of the hyaluronic acid and/or a metal ...

Подробнее
28-11-2013 дата публикации

NOVEL COMPOSITION FOR PREPARING POLYSACCHARIDE FIBERS

Номер: US20130313737A1
Автор: OBRIEN John P.
Принадлежит: E. I. DU PONT DE NEMOURS AND COMPANY

Solutions formed by combining poly(α(1→3) glucan) with CSin aqueous alkali metal hydroxide solution have been shown to produce the xanthated form of the poly(+(1→3) glucan). The solutions so formed have been shown to be useful for solution spinning into fiber of poly(α(1→3) glucan) when the spun fiber is coagulated in an acidic coagulation bath. The fibers so produced exhibit desirable physical properties. The poly(α(1→3) glucan) employed was synthesized by fermentation. 1. A solution comprising 0.75 to 2 molar aqueous alkali metal hydroxide and a solids content of 5 to 20% by weight of xanthated poly(α(1→3) glucan); wherein the number average molecular weight of the xanthated poly(α(1→3) glucan) is at least 10 ,000 Daltons; and , wherein the degree of xanthation of the poly(α(1→3) glucan) lies in the range of 0.1 to 1.2. The solution of wherein the solids content of xanthated poly(α(1→3) glucan) is in the range of 7.5 to 15%.3. The solution of wherein the alkali metal hydroxide is NaOH.4. The solution of wherein the concentration of NaOH is 1.0 to 1.7 molar.5. The solution of wherein the a xanthated poly(α(1→3) glucan) 100% of the linkages between glucose repeat units are α(1→3) glycoside linkages.6. The solution of wherein the number average molecular weight of the xanthated poly(α(1→3) glucan) is in the range of 40 claim 1 ,000-100 claim 1 ,000 Daltons.7. A process comprising forming a solution by dissolving in a 0.75 to 2 molar aqueous alkali metal hydroxide claim 1 , CS claim 1 , and 5 to 15 percent by weight of the total weight of the resulting solution of poly(α(1→3) glucan) characterized by a number average molecular weight of at least 10 claim 1 ,000 Da claim 1 , causing said solution to flow through a spinneret claim 1 , forming a fiber thereby; and contacting said fiber with an acidic liquid coagulant; wherein said process the weight ratio of CSto poly(α(1→3) glucan) lies in the range of 0.1 to 1.0.8. The process of wherein 7.5 to 15 percent by weight of ...

Подробнее
12-12-2013 дата публикации

CHITOSAN MANUFACTURING PROCESS

Номер: US20130331557A1
Автор: Bristow Joseph
Принадлежит: AGRATECH INTERNATIONAL, INC.

A method for producing chitosan from naturally occurring chitin-containing raw material, such as crustacean shells, includes an optional pretreatment step to remove non-chitin rich organic material for example, shrimp flesh, from the raw material, e.g., shrimp shells. The optional pretreatment is followed by a demineralization step utilizing a mild hydrochloric acid solution and a deproteination step utilizing a mild sodium hydroxide solution. The deproteination step is followed by a deacetylation step to remove the acetyl group from N-acetylglucosamine (chitin) to form an amine group, yielding d-glucosamine (chitosan). Each step is followed by a washing step and the product is dried, preferably at a temperature not in excess of about 65° C. Known purification and grinding steps may also be used to produce the final chitosan product. The process is carried out in equipment comprising a series of substantially identical or similar tanks ( etc.) and dryers (′), suitably interconnected. 1. A process for the manufacture of chitosan from a naturally occurring chitin source consists essentially of the following steps:(a) a naturally occurring chitin source is demineralized by immersing it in a demineralization (“DMIN”) hydrochloric acid solution of from about 0.5 to about 2 M at a temperature of from about 20° C. to about 30° C. and for a DMIN time period of from about 0.5 to about 2 hours to demineralize the chitin source, and then separating the resulting demineralized chitin source from the acid solution, washing the chitin source in a DMIN wash water for a DMIN wash period of from about 0.5 to about 2 hours to remove the hydrochloric acid and calcium salts therefrom, and then separating the demineralized chitin source from the DMIN wash water;(b) subjecting the demineralized chitin source to deproteination (“DPRO”) by treating the demineralized chitin source in a DPRO sodium hydroxide solution containing from about 1% to about 10% w/w NaOH for a DPRO time period of ...

Подробнее
19-12-2013 дата публикации

DERIVATIVE OF HYALURONIC ACID MODIFIED WITH AMINO-CARBOXYLIC ACID

Номер: US20130338352A1
Принадлежит: Chugai Seiyaku Kabushiki Kaisha

The present invention provides a hyaluronic acid derivative comprising disaccharide units of Formula (I), and a hyaluronic acid derivative/drug conjugate wherein one or more drugs are conjugated to the hyaluronic acid derivative. 2. The hyaluronic acid derivative according to claim 1 , wherein X is —NHCH claim 1 , —NH(CH)CHor —NR—CHR—CONRR claim 1 , or A is —CRR— or Ccycloalkylene.3. The hyaluronic acid derivative according to claim 1 , wherein{'sub': '3-8', 'A is Ccycloalkylene, and B is a direct bond;'}{'sub': 2', '2', '2', '3-8, 'A is —CH— or —CH—CH—, and B is selected from phenylene (wherein the phenylene may be substituted by one or more groups selected from hydroxy and halogen atoms), Ccycloalkylene and phenylmethane-1,1-diyl; or'}A is selected from 2-cyclohexylethane-1,1-diyl, 2-(2-naphthyl)ethane-1,1-diyl, 3-phenylpropane-1,1-diyl, cyclohexylmethane-1,1-diyl and 4-hydroxyphenylmethane-1,1-diyl, and B is a direct bond.4. The hyaluronic acid derivative according to claim 1 , wherein{'sub': '2', 'A is —CH—, and B is selected from cyclohexane-1,1-diyl, benzene-1,4-diyl, benzene-1,3-diyl, 2-chlorobenzene-1,4-diyl and phenylmethane-1,1-diyl;'}{'sub': 2', '2, 'A is —CHCH—, and B is benzene-1,4-diyl; or'}A is selected from 2-cyclohexylethane-1,1-diyl, 2-(2-naphthyl)ethane-1,1-diyl, and 3-phenylpropane-1,1-diyl; and B is a direct bond.7. The hyaluronic acid derivative according to claim 1 , which is prepared using hyaluronic acid composed exclusively of the disaccharide units each represented by Formula (II) as set forth in claim 1 , wherein claim 1 , when R claim 1 , R claim 1 , R claim 1 , and Rare all hydrogen atoms claim 1 , Ris acetyl claim 1 , and Xis —ONa claim 1 , the weight-average molecular weight is in the range of 20-120 kilodaltons.8. The hyaluronic acid derivative according to claim 1 , wherein an underivatized hyaluronic acid corresponding to the hyaluronic acid derivative in terms of backbone structure has a weight-average molecular weight of 20-120 ...

Подробнее
02-01-2014 дата публикации

HYDRAZIDO DERIVATIVES OF HYALURONIC ACID

Номер: US20140005141A1
Принадлежит:

Disclosed are chemically modified hyaluronic acid (HA) derivatives containing hydrazido groups directly linked to the glucuronic acid residues of HA. Said hydrazido groups are used to obtain crosslinked and labeled HA derivatives. The invention further relates to methods of preparation of said HA derivatives. 1. A hyaluronic acid (hereinafter HA) derivative or a salt thereof , said derivative having a part of the carboxy groups of the D-glucuronic residues converted directly into hydrazido groups.2. The hyaluronic acid derivative according to claim 1 , wherein said hyaluronic acid derivative is an uncross-linked compound represented by the formula:{'br': None, 'HA-CO—NR1—NHR2'}{'sub': 1', '20', '2', '20', '2', '10', '6', '14', '3', '2', '2', '1', '20', '2', '20', '2', '10', '1', '20', '2', '20', '6', '14, 'sup': '+', 'wherein R1and R2, the same or different, each is H, C-Calkyl, C-Calkenyl, C-Calkynyl, C-Caryl, alkaryl or heterocyclyl optionally substituted by one or more radicals selected from the group consisting of halogen, hydroxy, alkoxy, thioalkyl, nitro, cyano, CF, CONH, and —NH—NH, and/or each of the C-Calkyl, C-Calkenyl, C-Calkynyl may be interrupted by O or S or by a group NR3R4, wherein R3 and R4, the same or different; each is H, C-Calkyl, C-Calkenyl, C-Caryl.'}3. The hyaluronic acid derivative according to claim 2 , wherein said hyaluronic acid derivative is an uncross-linked claim 2 , water-soluble compound represented by the formula HA-CO-NH-NH.4. The hyaluronic acid derivative according to claim 3 , wherein said uncross-linked claim 3 , water-soluble compound further contains N-acylurea groups.5. The hyaluronic acid derivative according to claim 1 , wherein said hyaluronic acid derivative is a cross-linked compound formed by reaction of a part of the hydrazido groups of the D-glucuronic residues with a part of the carboxy groups of the D-glucuronic residues claim 1 , said carboxy groups being activated by a carbodiimide claim 1 , thus resulting in a ...

Подробнее
02-01-2014 дата публикации

Hyaluronic Acid-Gelatin Crosslinked Thermoreversible Pluronic Hydrogels

Номер: US20140005306A1
Принадлежит:

A HA-gelatin-pluronic hydrogel and a method for making a HA-gelatin-pluronic hydrogel are provided. The hydrogel includes hyaluronic acid, gelatin-Type A and a thermoreversible, hydrophilic non-ionic surfactant gel. The thermoreversible, hydrophilic non-ionic surfactant gel can be a poly(ethylene oxide)99-poly(propylene oxide)67-poly(ethylene oxide)99 (“Pluronic F127”). The weight ratio of HA to gelatin-Type A is between 1:2 and 2:1 and preferably about 1:1. The weight ratio of HA and gelatin-Type A to thermoreversible, hydrophilic non-ionic surfactant gel is between 1:3,000 and 1:150, preferably between 1:3,000 and 1:600 and most preferably about 1:2,400. The hydrogel is formed by combining hyaluronic acid and gelatin-Type A to form a solution, cooling the solution, mixing the solution with Pluronic F127 to form a mixture and storing the mixture at a temperature of from 25° C. to 45° C. preferably about 37° C., to form a gel 1. A hydrogel comprising:hyaluronic acid (“HA”);gelatin-Type A; anda thermoreversible, hydrophilic non-ionic surfactant gel.2. The hydrogel according to claim 1 , wherein the thermoreversible claim 1 , hydrophilic non-ionic surfactant gel is a poloxamer.3. The hydrogel according to claim 1 , wherein the gelatin-Type A has an isoelectric range between 7 and 9 pH.4. The hydrogel according to claim 1 , wherein the thermoreversible claim 1 , hydrophilic non-ionic surfactant gel is poly(ethylene oxide)99-poly(propylene oxide)67-poly(ethylene oxide)99 (“Pluronic F127”).5. The hydrogel according to claim 1 , wherein the weight ratio of HA to gelatin-Type A is between 1:2 and 2:1.6. The hydrogel according to claim 1 , wherein weight ratio of HA to gelatin-Type A is about 1:1.7. The hydrogel according to claim 1 , wherein the weight ratio of HA to gelatin-Type A is between 1:2 and 2:1 and the weight ratio of HA and gelatin-Type A to thermoreversible claim 1 , hydrophilic non-ionic surfactant gel is between 1:2 claim 1 ,400 and 1:150.9. The hydrogel ...

Подробнее
09-01-2014 дата публикации

Substrate-Independent Layer-By-Layer Assembly Using Catechol-Functionalized Polymers

Номер: US20140011956A1
Принадлежит: Northwestern University

The present invention provides a simple, non-destructive and versatile method that enables layer-by-layer (LbL) assembly to be performed on virtually any substrate. A novel catechol-functionalized polymer which adsorbs to virtually all surfaces and can serve as a platform for LbL assembly in a surface-independent fashion is also provided. 2. The catechol-functionalized polymer of wherein “x” is 221 and “y” is 122. This application is a divisional of U.S. application Ser. No. 13/622,136 filed Sep. 18, 2012, which is a continuation of U.S. application Ser. No. 12/267,822 filed Nov. 10, 2008 and issued as U.S. Pat. No. 8,293,867 on Oct. 23, 2012, which claims the benefit of U.S. Provisional Application No. 60/986,847 filed Nov. 9, 2007. Each of these applications is hereby incorporated by reference in its entirety for all purposes.This invention was made with government support under Grant No. DE014193 awarded by the National Institutes of Health. The government has certain rights in the invention.Layer-by-layer (LbL) assembly allows one to create multifunctional films on surfaces while maintaining the bulk properties of the individual surfaces [1]. The method relies on sequential adsorption of polymers onto bulk surfaces from solution, giving rise to complex multifunctional, multilayered films. LbL assembly is simple to implement and offers extensive control over film properties and composition during stepwise adsorption of components.Although the vast majority of LbL films are built from polyelectrolytes via electrostatic interaction between layers, more recently LbL films have been made with hydrogen bonding of polymers [2], and other building blocks such as inorganic nanoparticles, giving access to even greater control of chemical and physical properties of LbL films.In principle, LbL assembly can be performed on a wide variety of substrates, including noble metals (Au, Pt, etc.), oxides (quartz, Si, TiO, mica etc.), and synthetic polymers (polyethylene ...

Подробнее
09-01-2014 дата публикации

CROSS-LINKING OF LOW-MOLECULAR WEIGHT AND HIGH-MOLECULAR WEIGHT POLYSACCHARIDES, PREPARATION OF INJECTABLE MONOPHASE HYDROGELS, POLYSACCHARIDES AND HYDROGELS OBTAINED

Номер: US20140011990A1
Автор: Lebreton Pierre F.
Принадлежит: ALLERGAN INDUSTRIE SAS

A process for the crosslinking of at least one polymer selected from polysaccharides and derivatives thereof, which is carried out in an aqueous solvent by the action of an effective and non-excessive amount of at least one crosslinking agent, characterized in that it is carried out on a mixture containing at least one low-molecular weight polymer and at least one high-molecular weight polymer. A process for the preparation of an injectable monophase hydrogel of at least one crosslinked polymer selected from polysaccharides and derivatives thereof. Crosslinked polymers and injectable monophase hydrogels respectively obtainable by each of said processes. 1. An injectable polymeric composition prepared by a process comprising the steps of:{'sup': 5', '6, 'forming a mixture of a first hyaluronic acid salt having a first molecular weight of about 3×10Da and a second hyaluronic acid salt having a second molecular weight of about 3×10Da; and'}cross-linking the mixture formed in step 1) in an aqueous solvent in the presence of an effective and non-excessive amount of at least one cross-linking agent; andwherein the mixture contains more than 50% by weight of the first hyaluronic acid salt.2. The composition of wherein the mixture contains more than 70% by weight of the first hyaluronic acid salt.3. The composition of wherein at least one of the first hyaluronic acid salt and second hyaluronic acid salt is selected from a sodium salt claim 1 , a potassium salt claim 1 , and mixtures thereof.4. The composition of claim 1 , wherein the cross-linking agent is selected from epichlorohydrin claim 1 , divinyl sulfone claim 1 , 1 claim 1 ,4-bis(2 claim 1 ,3-epoxypropoxy) butane claim 1 , 1 claim 1 ,2-bis(2 claim 1 ,3-epoxypropoxy)ethylene claim 1 , 1-(2 claim 1 ,3-epoxypropyl)-2 claim 1 ,3-epoxycyclohexane claim 1 , aldehydes claim 1 , and mixtures thereof.5. The composition of claim 1 , wherein the cross-linking agent is 1 claim 1 ,4-butanediol diglycidyl ether (BDDE). This ...

Подробнее
09-01-2014 дата публикации

PROCESS FOR PRODUCING WATER-SOLUBLE HYALURONIC ACID MODIFICATION

Номер: US20140011991A1
Принадлежит: Chugai Seiyaku Kabushiki Kaisha

The present invention provides a water-soluble modified HA practically used as a drug carrier and a production method thereof. The present invention provides: a water-soluble modified hyaluronic acid, the residence time in blood of which is elongated to a practical level, which is produced by introducing a substituent into the carboxy group of the glucuronic acid of hyaluronic acid or a derivative thereof, via an amide bond, at a lower limit of an introduction ratio of 5 mole % or more, using a BOP condensing agent in an aprotic polar solvent; and a production method thereof. Moreover, by cross-linking the modified hyaluronic acid, the present invention provides a hyaluronic acid gel capable of extremely long drug sustained-release even at the same cross-linking functional group introduction ratio as that of the conventionally known gel. 2. The process according to claim 1 , which is used for encapsulation of a drug.3. The process according to claim 1 , wherein a drug which can be encapsulated is a conjugate consisting of a polymer and a drug.4. The process according to claim 1 , which further comprises drying the hyaluronic acid gel.5. The process according to claim 4 , which is used for encapsulation of a drug.6. The process according to claim 4 , wherein a drug which can be encapsulated is a conjugate consisting of a polymer and a drug. This is a divisional of application Ser. No. 13/430,259, filed Mar. 26, 2012, which is a divisional of U.S. Pat. No. 8,143,391, issued Mar. 27, 2012, (application Ser. No. 11/662,087, filed Mar. 7, 2007), which is the U.S. National Phase application of International Application No. PCT/JP2005/016389, filed Sep. 7, 2005, such applications claiming the benefit under 35 U.S.C. §119 of the filing dates of Application No. 2004/259157 filed in Japan on Sep. 7, 2004; Application No. 2005/064096 filed in Japan on Mar. 8, 2005; and Application No. 2005/064122 filed in Japan on Mar. 8, 2005, the contents of each of which are incorporated ...

Подробнее
30-01-2014 дата публикации

Process for electrospinning chitin fibers from chitinous biomass solution and fibers and articles produced thereby

Номер: US20140027938A1
Принадлежит: University of Alabama UA

Disclosed are methods for electrospinning chitinous biomass solution to form chitin fibers, using ionic liquids or other ion-containing liquids as solvent. Chitin fibers produced thereby and articles containing such chitin fibers are also disclosed. The chitin fiber thus obtained has very high surface area and improved strength over currently commercially available chitin materials.

Подробнее
13-03-2014 дата публикации

FLUID COMPOSITIONS FOR IMPROVING SKIN CONDITIONS

Номер: US20140073600A1
Автор: Lebreton Pierre F.
Принадлежит: ALLERGAN INDUSTRIE SAS

The present specification discloses fluid compositions comprising a matrix polymer and stabilizing component, methods of making such fluid compositions, and methods of treating skin conditions in an individual using such fluid compositions. 1. A method of making a fluid composition , the method comprising the steps of:a) combining mannitol with a physiologically-acceptable buffer to make a mannitol-buffered solution, wherein the mannitol is present in at about 0.5% (w/v) to about 5% (w/v) of the solution;b) combining a hyaluronan polymer with the mannitol-buffered solution to hydrate the hyaluronan polymer, wherein the hyaluronan polymer is present at a concentration of about 11.5 mg/mL to about 15.5 mg/mL and wherein the hyaluronan polymer is substantially uncrosslinked.2. The method of further comprising the step ofc) sizing the fluid composition by recirculating the fluid composition between a first vessel and a second vessel through a narrow aperture.3. The method of wherein the fluid composition has a dynamic viscosity of about 50 Pa·s to about 150 Pa·s.4. The method of wherein the fluid composition has an osmolarity of about 200 mOsm/L to about 400 mOsm/L.5. A method of improving a skin condition of an individual claim 1 , the method comprising the steps of:administering a dermal filler into a dermal region of the individual, wherein the dermal filler comprises a hyaluronan polymer composition consisting essentially of uncrosslinked hyaluronic acid and mannitol present in at about 0.5% (w/v) to about 5% (w/v) of the composition, wherein the administration improves the skin condition.6. The method of wherein the uncrosslinked hyaluronic acid contains at least 95% by weight of a hyaluronic acid having a mean molecular weight of at least about 2 claim 5 ,500 claim 5 ,000 Da.7. The method of claim 5 , wherein the skin conditions treated is skin dehydration claim 5 , a lack of skin elasticity claim 5 , skin roughness claim 5 , a lack of skin tautness claim 5 , a ...

Подробнее
20-03-2014 дата публикации

Process for Improving the Flow Rate of an Aqueous Dispersion

Номер: US20140080944A1
Принадлежит: Hercules Inc

A process for improving the flow rate of an aqueous dispersion which comprises adding a natural polymer to said aqueous system and then adding a synthetic polymer to the aqueous system. 1. A process for improving the flow rate of an aqueous dispersion comprising(a) adding a natural polymer to the aqueous dispersion, and(b) then adding a synthetic polymer to the aqueous dispersion, wherein the natural polymer and the synthetic polymer is an amount effective to increase the flow rate of the aqueous dispersion.2. The process of wherein the natural polymer is a polysaccharide.3. The process of wherein the polysaccharide is a dextran.4. The process of wherein the synthetic polymer is selected from the group consisting of water soluble anionic polymers claim 3 , cationic polymers claim 3 , amphoteric polymers claim 3 , nonionic polymers claim 3 , and mixtures thereof.5. The process of wherein the synthetic polymer is an anionic polymer.6. The process of wherein the anionic polymer is selected from the group consisting of copolymers derived from 2-acrylamido 2-methylpropane sulfonic acid claim 5 , copolymers of acrylic acid and acrylamide claim 5 , homopolymers of acrylic acid claim 5 , homopolymers of acrylamide claim 5 , and combinations thereof.7. The process of wherein the anionic polymer comprises a copolymer of sodium acrylate and acrylamide or a copolymer of acrylic acid and acrylamide.8. The process of wherein the pH of the anionic polymer is about 5 to about 10.9. The process of wherein Mw of the dextran is about 5 claim 5 ,000 to about 40 claim 5 ,000 claim 5 ,0000.10. The process of wherein Mw of the anionic polymer is about 500 claim 9 ,000 to about 25 claim 9 ,000 claim 9 ,000.11. The process of wherein the PDI of the dextran is about 1.0 to about 0.12. The process of wherein weight ratio of natural polymer and synthetic polymer is a ratio effective to increase the flow rate of the aqueous dispersion.13. The process of wherein weight ratio of natural polymer ...

Подробнее
20-03-2014 дата публикации

Process for Improving the Rheological Properties of an Aqueous Dispersion

Номер: US20140080945A1
Принадлежит: HERCULES LLC

A process for improving the rheological properties of an aqueous dispersion comprising adding a rheology modifier to the aqueous dispersion, and then adding a water soluble synthetic polymer flocculant to the aqueous dispersion. The rheology modifier may be selected from the group consisting of natural polymers, semi-natural polymers, synthetic materials and combinations thereof. The water soluble synthetic polymer flocculant may be selected from the group consisting of water soluble anionic polymers, cationic polymers, amphoteric polymers, nonionic polymers, and combinations thereof.

Подробнее
03-04-2014 дата публикации

Outer layer having entanglement of hydrophobic polymer host and hydrophilic polymer guest

Номер: US20140093717A1

An outer layer having an entanglement comprising an intermingling of cloaked hydrophilic guest and a hydrophobic polymer host, wherein molecules of the guest have been crosslinked with each other. Under certain circumstances, using complexes of the guest may be desirable or even necessary. The intermingling of the guest and host includes a physical tangling, whether it also comprises crosslinking by primary bonding (e.g., chemical/covalent bonding) there-between. Also a method of producing an outer layer having such an entanglement, including the steps of: temporarily cloaking at least a portion of the hydrophilic groups of the guest; intermingling at least a portion of the cloaked groups with a porous polymeric structure by diffusing the guest with cloaked groups into at least a portion of the structure's pores; within the pores, crosslinking at least a portion of the molecules of the guest with the guest; and removing the cloaking. Cloaking may be performed by silylation or acylation. Intermingling may be performed by producing a mixture of guest and host (whether in solution, powdered, granular, etc., form); next, a crosslinking of the guest with itself is performed; then, the mixture is molded into the outer layer.

Подробнее
10-04-2014 дата публикации

EXTRACTION OF CHITINS IN A SINGLE STEP BY ENZYMATIC HYDROLYSIS IN AN ACID MEDIUM

Номер: US20140100361A1

A method of enzymatic extraction of chitin is realized in a single step wherein the chitin is obtained by enzymatic hydrolysis of raw material constituted by animal biomass including chitin, the enzymatic hydrolysis using an enzyme active in acid medium. Also disclosed is a process of optimization of the method of enzymatic extraction of chitin, as well as the chitin susceptible to be obtained by the method of enzymatic extraction. 1. A method for the enzymatic extraction of chitin , wherein said method is carried out in a single step , wherein chitin is obtained by the enzymatic hydrolyzis of raw material constituted by animal biomass comprising chitin , said enzymatic hydrolyzis using an active enzyme in an acid medium.2. A method according to claim 1 , wherein said single step is an enzymatic hydrolysis for deproteinizing and demineralizing said raw material simultaneously.3. A method according to claim 1 , wherein said enzyme active in an acid medium is a protease having a broad spectrum of activity in an acid medium claim 1 , preferably pepsin or a stable acid protease.4. A method according to claim 1 , wherein the enzyme concentration used for hydrolysis is 0.1 to 75% claim 1 , preferably 5 to 30% claim 1 , more preferably from approximately 23 to approximately 27% in weight relative to the estimated weight of the protein in the raw material.5. A method according to claim 1 , wherein the acid medium is obtained by means of the presence of an acid claim 1 , preferably a dietary acid claim 1 , more preferably phosphoric acid or formic acid.6. A method according to claim 1 , wherein animal biomass comprising chitin comprises marine by-products claim 1 , preferably marine by-products obtained from crustaceans claim 1 , preferably prawns claim 1 , crabs or krill claim 1 , or from cephalopods claim 1 , preferably squid or cuttlefish.7. A method according to claim 1 , wherein said animal biomass comprising chitin comprises insect by-products claim 1 , preferably ...

Подробнее
07-01-2021 дата публикации

NOVEL MUCOSAL ADJUVANTS AND DELIVERY SYSTEMS

Номер: US20210000947A1

Adjuvants comprising chitosan cross-linked with an aldehyde or mannosylated chitosan are provided herein. Methods of making the adjuvants and methods of combining or linking the adjuvants with antigens are also provided. The adjuvant-antigen combinations can be used in vaccine formulations and the vaccine formulations can be used in methods to vaccinate animals against the source of the antigen or to enhance the immune response in a subject. 1. An adjuvant composition comprising a carbohydrate linked to chitosan to form a Schiff base.2. The composition of claim 1 , wherein the carbohydrate is selected from mannose claim 1 , mannobiose claim 1 , glucose claim 1 , galactose claim 1 , or fructose.3. The composition of claim 2 , wherein the carbohydrate is mannose.4. The composition of any one of - claim 2 , wherein the Schiff base is not reduced.5. The composition of any one of - claim 2 , wherein the Schiff base is reduced.6. An adjuvant composition comprising between 0.5% and 2% of an aldehyde cross-linked chitosan.7. The composition of claim 6 , wherein the chitosan is cross-linked with formaldehyde.8. The composition of or claim 6 , further comprising Tris-HCl to quench free aldehydes.9. The composition of any one of - claim 6 , further comprising an enhancing molecule.10. The composition of claim 9 , wherein the enhancing molecule is saponin claim 9 , toll-like receptors claim 9 , the B subunit of a bacterial toxin claim 9 , bacterial toxins claim 9 , CpG motifs claim 9 , liposomes or monophosphoryl lipid A.11. The composition of claim 9 , wherein the enhancing molecule is tetanus toxoid claim 9 , cholera toxin B subunit claim 9 , heat labile enterotoxin B subunit claim 9 , or tripolyphosphate.12. A vaccine formulation comprising the adjuvant composition of any one of - and an antigen.13. The vaccine of claim 12 , wherein the antigen is a protein.14InfluenzaEimeriaClostridium. The vaccine of claim 13 , wherein the protein is M2e claim 13 , Hemaglutinin claim 13 , ...

Подробнее
04-01-2018 дата публикации

COMPOSITIONS OF JASMONATE COMPOUNDS AND METHODS OF USE

Номер: US20180000958A1
Принадлежит:

The disclosure describes nanocarried and/or microcarried jasmonate compounds and their pharmaceutical compositions, as well as use thereof for treating or preventing angiogenesis-related or NF-κB-related disorders. Also disclosed are methods of making the nanocarried and/or microcarried compounds and their compositions. 1. A pharmaceutical composition comprising a pharmaceutically acceptable solvent and a plurality of nanocarriers or microcarriers that contain a jasmonate compound , whereinthe nanocarriers or microcarriers are formed of a cyclodextrin or a dendrimer, or are synthetic nanoemulsion particles (LDEs) comprising a cholesteryl ester core surrounded by a phospholipid layer;the nanocarriers have a size ranging from 1 nanometer (nm) to 900 nm; orthe microcarriers have a size ranging from 1 micron to 50 micron; andthe pharmaceutical composition has a concentration of the jasmonate compound ranging from 1 nM to 1 M.2. The pharmaceutical composition of claim 1 , wherein the jasmonate compound is selected from the group consisting of jasmonic acid claim 1 , 7-iso -jasmonic acid claim 1 , 9 claim 1 ,10-dihydrojasmonic acid claim 1 , 9 claim 1 ,10-dihydro-isojasmonic acid claim 1 , 2 claim 1 ,3-didehydrojasmonic acid claim 1 , 3 claim 1 ,4-didehydrojasmonic acid claim 1 , 3 claim 1 ,7-didehydrojasmonic acid claim 1 , 4 claim 1 ,5-didehydrojasmonic acid claim 1 , 4 claim 1 ,5-didehydro-7-isojasmonic acid claim 1 , cucurbic acid claim 1 , 6-epi-cucurbic acid claim 1 , 6-epi-cucurbic acid-lactone claim 1 , 12-hydroxy-jasmonic acid claim 1 , 12-hydroxy-jasmonic acid-lactone claim 1 , 11-hydroxy-jasmonic acid claim 1 , 8-hydroxy-jasmonic acid claim 1 , homo-jasmonic acid claim 1 , dihomo-jasmonic acid claim 1 , 11-hydroxy-dihomo-jasmonic acid claim 1 , 8-hydroxy-dihomo-jasmonic acid claim 1 , tuberonic acid claim 1 , tuberonic acid-O-β-glucopyranoside claim 1 , cucurbic acid-O-β-glucopyranoside claim 1 , 5 claim 1 ,6-didehydro-jasmonic acid claim 1 , 6 claim 1 ,7- ...

Подробнее
07-01-2016 дата публикации

METHOD OF MANUFACTURING THREE-DIMENSIONAL STRUCTURE, THREE-DIMENSIONAL STRUCTURE, AND THREE-DIMENSION FORMATION COMPOSITION

Номер: US20160001506A1
Принадлежит:

There is provided a method of manufacturing a three-dimensional structure, in which the three-dimensional structure is manufactured by laminating a layer, the method including: forming the layer using a three-dimension formation composition containing particles, a binding resin, and a solvent; applying a binding solution containing a binder to the layer; and removing the particles, which are not bound by the binder, using a removing solution after repeating the forming of the layer and the applying of the binding solution, in which, in the removing of the unbound particles, the binding resin has a water-soluble functional group whose pKa in water is less than the pH of the removing solution. 1. A method of manufacturing a three-dimensional structure , in which the three-dimensional structure is manufactured by laminating a layer , the method comprising:forming the layer using a three-dimension formation composition containing particles, a binding resin, and a solvent;applying a binding solution containing a binder to the layer; andremoving the particles, which are not bound by the binder, using a removing solution after repeating the forming of the layer and the applying of the binding solution,wherein, in the removing of the unbound particles, the binding resin has a water-soluble functional group whose pKa in water is less than the pH of the removing solution.2. The method of manufacturing a three-dimensional structure according to claim 1 ,wherein the pKa of the water-soluble functional group in water is 6 or less.3. The method of manufacturing a three-dimensional structure according to claim 1 ,wherein the water-soluble functional group is a carboxyl group or a sulfo group.4. The method of manufacturing a three-dimensional structure according to claim 1 ,wherein the binding resin having a carboxyl group as the water-soluble functional group contains one or more selected from the group consisting of a reaction product of an olefin-maleic anhydride copolymer with ...

Подробнее
04-01-2018 дата публикации

CHITIN, HYDROLYSATE AND METHOD FOR THE PRODUCTION OF ONE OR MORE DESIRED PRODUCTS BY MEANS OF ENZYMATIC HYDROLYSIS, INCLUDING PRE-TREATMENT WITH AN OXIDISING AGENT

Номер: US20180002452A1
Принадлежит: YNSECT

The invention relates to chitin, a hydrolysate and a method for the production of at least one desired product from insects. More specifically, the invention relates to a method for the production of chitin and/or chitosan from insect cuticles, comprising a step in which insect cuticles are treated with an oxidising agent, followed by a step involving the enzymatic hydrolysis of the insect cuticles using a proteolytic enzyme. 1. Hydrolysate comprising at least 40% by weight proteins based on the total weight of dry matter , at a maximum 10% by weight ash based on the total weight of dry matter , and a water-soluble protein content larger than 12 ,400 g/mol less than 50%.2. Chitin comprising an amino acid content less than or equal to 55% by weight based on the total weight of dry matter , an ash content less than or equal to 3.5% by weight based on the total weight of dry matter , and a purity by difference greater than or equal to 35% or a colorimetric purity greater than or equal to 44%.3. Method for the production of chitin and/or chitosan from insect cuticles , comprising the following steps:(i) treating the insect cuticles with an oxidizing agent, then(ii) enzymatic hydrolysis of the insect cuticles with a proteolytic enzyme.4. Method according to claim 3 , in which the proteolytic enzyme is a protease.5. Method according to or claim 3 , in which the oxidizing agent is selected from the group constituted by hydrogen peroxide claim 3 , potassium permanganate claim 3 , ozone and sodium hypochlorite.6. Method according to any one of to claim 3 , comprising a step of killing the insects.7. Method according to any one of to claim 3 , comprising a step of grinding the insects.8. Method according to any one of to claim 3 , in which the oxidizing agent is hydrogen peroxide.9. Method according to any one of to claim 3 , in which the insect or insects is/are selected from the group constituted by the Coleoptera claim 3 , the Lepidoptera claim 3 , the Orthoptera and the ...

Подробнее
02-01-2020 дата публикации

METHOD FOR CLEAVING AMIDE BONDS

Номер: US20200002440A1
Принадлежит: GALDERMA S.A.

A method for cleaving amide bonds, including: a) providing a molecule including an amide group; b) reacting the molecule including the amide group with a hydroxylamine salt to cleave the amide bond of the amide group. The method may further include c) recovering a product formed by the reaction of step b). 131.-. (canceled)32. A method for cleaving amide bonds , comprising:a) providing a molecule comprising an amide group, wherein the amide group is a primary, secondary or tertiary amide group;b) reacting the molecule comprising an amide group with a hydroxylamine salt to cleave the amide bond of the amide group.33. The method according to claim 32 , wherein the method further comprises:c) recovering a product formed by the reaction of step b).34. The method according to claim 32 , wherein the amide group is an N-acyl amide group claim 32 , preferably an N-acetyl amide group.35. The method according to claim 32 , wherein the molecule comprising an amide group further comprises a pH sensitive chiral center.36. The method according to claim 32 , wherein the molecule comprising an amide group further comprises a pH sensitive protecting group.37. The method according to claim 32 , wherein step b) comprises reacting the molecule comprising an amide group with the hydroxylamine salt at a temperature of 100° C. or less.38. The method according to claim 32 , wherein step b) comprises reacting the molecule comprising an amide group with the hydroxylamine salt for 2-200 hours.39. The method according to claim 32 , wherein the hydroxylamine salt is a salt formed by hydroxylamine and an acid selected from the group consisting of mineral acids and organic acids or mixtures thereof.40. The method according to claim 32 , wherein the hydroxylamine salt is a salt formed by hydroxylamine and an acid selected from the group consisting of hydrochloric acid claim 32 , hydroiodic acid claim 32 , hydrobromic acid claim 32 , acetic acid claim 32 , propionic acid claim 32 , pivalic acid ...

Подробнее
07-01-2021 дата публикации

HETEROPOLYSACCHARIDES

Номер: US20210002389A1
Принадлежит:

The present invention relates a heteropolysaccharide characterized in that it is substantially composed of the monosaccharides glucose and galactose and rhamnose and N-acetylgalactosamine and a process for the production thereof. The invention further relates to a bacterium capable of producing said heteropolysaccharide and to the use of the heteropolysaccharide and the bacterium for improving the texture of fermented milk products. 1Streptococcus thermophilus.. A fermented milk product comprising a heteropolysaccharide composed of at least about 90% , based on dry matter , of monosaccharides glucose and galactose and rhamnose and N-acetylgalactosamine , and wherein the heteropolysaccharide has a molecular weight of 400 kDa to 4000 kDa , wherein the heteropolysaccharide comprises a repeating unit whereby the repeating unit is a pentasaccharide composed of the monosaccharides glucose and galactose and rhamnose and N-acetylgalactosamine , and wherein the pentasaccharide has the following composition:glucose:galactose:rhamnose:N-acetylgalactosamine=2:1:1:1 , wherein the heteropolysaccharide is from2. The fermented milk product according to claim 1 , wherein the heteropolysaccharide comprises 30-50 mole % glucose claim 1 , 10-30 mole % galactose claim 1 , 10-30 mole % rhamnose and 10-30 mole % N-acetylgalactosamine and whereby the total mole % is 100%.3. The fermented milk product according to claim 2 , wherein the ratio of the mole % of glucose and the mole % of galactose is between ≥1.0 and ≤2.0.4. The fermented milk product according to claim 2 , wherein the heteropolysaccharide comprises 40 mole % glucose claim 2 , 20 mole % galactose claim 2 , 20 mole % rhamnose and 20 mole % N-acetylgalactosamine.5. The fermented milk product according to claim 1 , wherein the pentasaccharide is composed of 40 mole % glucose claim 1 , 20 mole % galactose claim 1 , 20 mole % rhamnose and 20 mole % N-acetylgalactosamine.6. The fermented milk product comprising the ...

Подробнее
03-01-2019 дата публикации

Chitosan-Derived Compositions

Номер: US20190002594A1
Принадлежит:

The present invention relates generally to therapeutic compositions comprising chitosan-derived compositions used in connection with methods for treating neoplasms, such as for instance, malignant lung, thyroid and kidney neoplasms, and other types of malignant neoplasms, and other medical disorders. 1. A method of treating cancer in a subject , the method comprising:administering to the subject in need thereof, a viscoelastic glycated chitosan formulation of filter sterilized glycated chitosan polymer and a substantially aqueous solution, the glycated chitosan polymer having a molecular weight between about 50,000 Daltons to about 1,500,000 Daltons, the glycated chitosan polymer having glycated amino groups present from about one tenth of one percent to about thirty percent of available amino groups, the degree of deacetylation of a chitosan parent of the viscoelastic glycated chitosan is about 80%,wherein the substantially aqueous solution having a pH from between about 5 to about 7, wherein about one percent by weight of the glycated chitosan polymer is dissolved in the substantially aqueous solution, andwherein the aqueous solution has a viscosity from about one centistokes to about one hundred centistokes measured at about 25 degrees Celsius.2. The method claim 1 , according to claim 1 , in which the formulation is administered by injection to the subject.3. The method claim 1 , according to claim 1 , in which the glycated chitosan polymer has a molecular weight less than 500 claim 1 ,000 Daltons.4. The method claim 1 , according to claim 1 , further includes treating the cancer using a combination of the formulation and radiation treatment.5. The method claim 1 , according to claim 1 , further includes treating the cancer with a combination of the formulation and an anti-neoplastic drug.6. The method claim 1 , according to claim 1 , in which the anti-neoplastic drug is selected from the group consisting of: alkylating agents; antimetabolites; plant alkaloids; ...

Подробнее
04-01-2018 дата публикации

NANOGELS FOR DELAYED GELATION

Номер: US20180002592A1
Принадлежит:

The instant application relates to nanogels or compositions that hold multivalent metal ions until some level of nanogel degradation has occurred, then slowly release the multivalent metal ions for gelation with carboxylate containing polymers. Compositions comprising such nanogels, together with polymers that can be crosslinked with multivalent metal ions, allow the deployment of such mixtures in various applications, and greatly increased gelation times. 1) A degradable composition comprising a polymer having releasable carboxylate groups bound to with a multivalent metal ion , said degradable composition lasting at least 5 days at 85° C. in a brine solution having 23 g/l NaCl , and thereafter degrading and releasing said multivalent metal ion , wherein said composition is in the form of a nanogel.2) The composition of claim 1 , wherein said nanogel has an average particle size of less than one micron.3) The composition of claim 1 , wherein said nanogel has an average particle size of 200-600 nm.4) The composition of claim 1 , wherein said nanogel has an average particle size of 400 nm.5) The composition of claim 1 , wherein said polymer is made from monomers selected from the group of vinyl claim 1 , allyl claim 1 , styrene claim 1 , and acrylamide monomers and their derivatives claim 1 , conjugated with a dicarboxylate or tricarboxylate.6) The composition of claim 5 , wherein said dicarboxylate or tricarboxylate is citrate claim 5 , succinate claim 5 , aspartate claim 5 , glutamate claim 5 , malate claim 5 , oxalate claim 5 , malonate claim 5 , glutarate claim 5 , adipate claim 5 , or pimelate claim 5 , or a derivative thereof.7) The composition of claim 1 , wherein said polymer is carboxylated polysaccharide claim 1 , carboxylated guar claim 1 , or carboxymethyl cellulose.8) The composition of claim 1 , wherein said polymer having releasable carboxylate groups is a polymer or copolymer of succinate claim 1 , aspartate claim 1 , malate claim 1 , oxalate claim 1 ...

Подробнее
13-01-2022 дата публикации

BIODEGRADABLE MICROCAPSULES

Номер: US20220008886A1
Принадлежит:

Disclosed are biodegradable core-shell microcapsule compositions composed of microcapsules having a wall formed by self-condensation of an isocyanate in the presence of a denatured pea protein as dispersant. Also disclosed are consumer products containing such a core-shell microcapsule composition and methods for producing core-shell microcapsule compositions. 1. A core-shell microcapsule composition comprising:(a) microcapsules having a mean diameter of 1 to 100 microns, the core of the microcapsules comprises an active material and the shell of the microcapsules comprises a trimethylol propane-adduct of xylylene diisocyanate;(b) a dispersant comprising denatured pea protein; and(c) a hydrocolloid comprising gum arabic.2. The core-shell microcapsule composition of claim 1 , further comprising least one rheology modifier claim 1 , preservative claim 1 , emulsifier claim 1 , or a combination thereof.3. The core-shell microcapsule composition of claim 2 , wherein the rheology modifier comprises xanthan gum.4. The core-shell microcapsule composition of claim 1 , wherein the trimethylol propane-adduct of xylylene diisocyanate is present at 0.1% to 8% by weight of the core-shell microcapsule composition.5. The core-shell microcapsule composition of claim 1 , wherein the active material comprises at least one fragrance claim 1 , pro-fragrance claim 1 , malodor counteractive agent claim 1 , or a combination thereof.6. A consumer product comprising the core-shell microcapsule composition of .7. The consumer product of claim 6 , wherein the consumer product is a fabric softener claim 6 , a fabric refresher claim 6 , or a liquid laundry detergent.8. A method for producing a core-shell microcapsule composition comprising: (i) denaturing a pea protein,', '(ii) adjusting the pH to below 6, and', '(iii) adding gum arabic as a hydrocolloid;, '(a) preparing an aqueous phase by'}(b) preparing an oil phase comprising an active material and a trimethylol propane-adduct of xylylene ...

Подробнее
13-01-2022 дата публикации

GREEN METHOD TO PREPARE PLAIN WATER-BASED POLYSACCHARIDE CHITOSAN SOLUTIONS

Номер: US20220010076A1
Автор: LI Boxuan, Wang Juan, YANG Hu
Принадлежит: Virginia Commonwealth University

A method is provided for producing a composition comprising chitosan and water, comprising dissolving chitosan powder in an ionic liquid, to prepare a first composition comprising chitosan and ionic liquid; and contacting the first composition with water under conditions sufficient to solvent-exchange all or substantially all of the ionic liquid with water; to form a composition comprising chitosan and water. Compositions produced thereby and methods of using the compositions are provided. 1. A method for producing a composition comprising chitosan and water , comprising:dissolving chitosan powder in an ionic liquid, to prepare a first composition comprising chitosan and ionic liquid; andcontacting the first composition with water under conditions sufficient to solvent-exchange all or substantially all of the ionic liquid with water;to form a composition comprising chitosan and water.2. The method of claim 1 , further comprising claim 1 , after the dissolving and prior to the contacting claim 1 , freezing the first composition to form a frozen composition comprising chitosan and the ionic liquid claim 1 , wherein said contacting the first composition comprises contacting the frozen composition.3. The method of claim 1 , further comprising vortexing the composition comprising chitosan and water.4. The method of claim 1 , wherein the composition comprising chitosan and water comprises chitosan solutes having a size in the range of 1 to 1 claim 1 ,000 nm.5. The method of claim 1 , further comprising removing excess water from the composition comprising chitosan and water.6. The method of claim 1 , wherein the ionic liquid is hydrophilic.7. The method of claim 1 , wherein the ionic liquid is one or more of 1-allyl-3-methyl-imidazolium bromide; 1-allyl-3-methyl-imidazolium chloride; 1-butyl-3-methyl-imidazolium acetate; 1-butyl-3-methyl-imidazolium chloride; 1-ethyl-3-methyl-imidazolium acetate; 1-ethyl-3-methyl-imidazolium chloride; 1-ethyl-3-methyl-imidazolium dimethyl ...

Подробнее
11-01-2018 дата публикации

Dually Derivatized Chitosan Nanoparticles and Methods of Making and Using the Same for Gene Transfer In Vivo

Номер: US20180008720A1
Принадлежит:

Provided herein is chitosan dually derivatized with arginine and gluconic acid; and methods of making and using the same, e.g., for gene delivery in vivo. 114.-. (canceled)15. A method of treating diabetes comprising administering a therapeutically effective amount of a therapeutic nucleic acid encoding insulin , a glucagon antagonist , GLP-1 or leptin to a target tissue in a patient , wherein said administering comprises contacting said target tissue with a dually derivatized (DD) chitosan nucleic acid polyplex , said DD chitosan nucleic acid polyplex comprising a chitosan-derivative nanoparticle comprising chitosan coupled with gluconic acid and arginine , and said therapeutic nucleic acid.16. A method of treating inflammatory bowel disease comprising administering a therapeutically effective amount of a therapeutic nucleic acid encoding IL-10 , a TNFα antagonist , or an IL-17 antagonist to a target tissue in a patient , wherein said administering comprises contacting said target tissue with a dually derivatized (DD) chitosan nucleic acid polyplex , said DD chitosan nucleic acid polyplex comprising a chitosan-derivative nanoparticle comprising chitosan coupled with gluconic acid and arginine , and said therapeutic nucleic acid.17. A method of treating of obesity comprising administering a therapeutically effective amount of a therapeutic nucleic acid encoding leptin , cholecystokinin , PYY or GLP-1 to a target tissue in a patient , wherein said administering comprises contacting said target tissue with a dually derivatized (DD) chitosan nucleic acid polyplex , said DD chitosan nucleic acid polyplex comprising a chitosan-derivative nanoparticle comprising chitosan coupled with gluconic acid and arginine , and said therapeutic nucleic acid.18. The method according to , , or , wherein said nanoparticle comprises arginine at a concentration of about 10% to about 55%.19. The method according to claim 18 , wherein said nanoparticle comprises gluconic acid at an initial ...

Подробнее
14-01-2021 дата публикации

POROUS BIOMATERIALS FOR TISSUE REGENERATION

Номер: US20210008249A1
Принадлежит:

The present invention relates to a porous material having a scaffold comprising: one or more fibroin moieties A and one or more polysaccharide moieties B, wherein A and B are directly conjugated with another without an interconnecting linker structure. Moreover, the present invention refers to a method for preparing a porous material. The present invention further relates to an injectable composition comprising a particulate porous material according to the invention and to cosmetic and therapeutic uses thereof such as facial and body re-shaping as well as regenerating tissue. 118-. (canceled)19. A porous material having a scaffold comprising:one or more fibroin moieties A; andone or more polysaccharide moieties B,wherein A and B are directly conjugated with another without an interconnecting linker structure.20. The porous material of claim 19 , wherein one or more lysyl residues of the one or more fibroin moieties A are directly covalently bound to one or more carbon atoms of the one or more polysaccharide moieties B via double bond or via single bond.21. The porous material of claim 19 , wherein the one or more polysaccharide moieties B have a weight average molecular weight in the range of 50 to 2000 kDa.22. The porous material of claim 19 , wherein the one or more polysaccharide moieties B are selected from the group consisting of hyaluronic acid moieties claim 19 , cellulose moieties claim 19 , heparosan moieties claim 19 , and mixtures of two or more thereof.23. The porous material of claim 19 , wherein the ratio between fibroin moieties A and polysaccharide moieties B is in the range of 1:10 to 10:1.24. The porous material of claim 19 , wherein said porous material bears pores of a mean average pore diameter in the range of from 20 to 400 μm.25. The porous material of claim 19 , wherein said porous material is particulate and bears a mass average particle size that is at least 5-fold larger than the mean average pore diameter.26. A method for preparing a ...

Подробнее
10-01-2019 дата публикации

MICELLAR NANOCOMPLEX

Номер: US20190008830A1
Принадлежит:

The present invention relates to micellar nanocomplexes and a method of forming the same. The micellar nanocomplex comprises a micelle and an agent encapsulated within said micelle, where the micelle comprises a polymer-flavonoid conjugate, wherein said polymer is bonded to the B ring of said flavonoid. The micellar nanocomplex may have useful applications as a drug-delivery system. 124-. (canceled)25. A polymer-flavonoid conjugate comprising a polymer bonded to the B ring of a flavonoid.26. The polymer-flavonoid conjugate of claim 25 , wherein said polymer is selected from the group consisting of a polysaccharide claim 25 , polyacrylamide claim 25 , poly(N-isopropylacrylamide) claim 25 , poly(oxazoline) claim 25 , polyethylenimine claim 25 , poly(acrylic acid) claim 25 , polymethacrylate claim 25 , poly(ethylene glycol) claim 25 , poly(ethylene oxide) claim 25 , poly(vinyl alcohol) claim 25 , poly(vinylpyrrolidinone) claim 25 , polyethers claim 25 , poly(allylamine) claim 25 , polyanhydrides claim 25 , poly(β-amino ester) claim 25 , poly(butylene succinate) claim 25 , polycaprolactone claim 25 , polycarbonate claim 25 , polydioxanone claim 25 , poly(glycerol) claim 25 , polyglycolic acid claim 25 , poly(3-hydroxypropionic acid) claim 25 , poly(2-hydroxyethyl methacrylate) claim 25 , poly(N-(2-hydroxypropyl)methacrylamide) claim 25 , polylactic acid claim 25 , poly(lactic-co-glycolic acid) claim 25 , poly(ortho esters) claim 25 , poly(2-oxazoline) claim 25 , poly(sebacic acid) claim 25 , poly(terephthalate-co-phosphate) and copolymers thereof.27. The polymer-flavonoid conjugate of claim 25 , wherein said flavonoid is selected from the group consisting of (−)-epicatechin claim 25 , (+)-epicatechin claim 25 , (−)-catechin claim 25 , (+)-catechin claim 25 , epicatechin gallate claim 25 , epigallocatechin claim 25 , epigallocatechin gallate claim 25 , Fisetinidol claim 25 , Gallocatechin claim 25 , Gallocatechin gallate claim 25 , Mesquitol and Robinetinidol claim 25 , ...

Подробнее
09-01-2020 дата публикации

THREADS OF HYALURONIC ACID AND/OR DERIVATIVES THEREOF, METHODS OF MAKING THEREOF AND USES THEREOF

Номер: US20200009038A1
Принадлежит:

The present invention provides threads of hyaluronic acid, and/or derivatives thereof, methods of making thereof and uses thereof, for example, in aesthetic applications (e.g., dermal fillers), surgery (sutures), drug delivery, etc. 1. An implantable device comprising:a thread comprising uncrosslinked hyaluronic acid or salts, hydrates or solvates thereof and crosslinked hyaluronic acid or salts, hydrates or solvates thereof.2. The device of claim 1 , wherein the crosslinked hyaluronic acid is crosslinked with a crosslinker selected from the group consisting of butanediol diglycidyl ether (BDDE) claim 1 , divinyl sulfone (DVS) and 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC).3. The device of claim 1 , wherein the crosslinked hyaluronic acid is crosslinked with butanediol diglycidyl ether (BDDE).4. The device of claim 1 , wherein the thread further comprises a therapeutic agent.5. The device of claim 4 , wherein the therapeutic agent is selected from the group consisting of lidocaine claim 4 , xylocaine claim 4 , novocaine claim 4 , benzocaine claim 4 , prilocaine claim 4 , ropivacaine claim 4 , propofol claim 4 , and combinations thereof.6. The device of claim 4 , wherein the therapeutic agent is lidocaine.7. The device of claim 4 , wherein the therapeutic agent is selected from the group consisting of epinephrine claim 4 , adrenaline claim 4 , ephedrine claim 4 , aminophylline claim 4 , theophylline claim 4 , and combinations thereof.8. The device of claim 4 , wherein the therapeutic agent is botulism toxin.9. The device of claim 4 , wherein the therapeutic agent is laminin-511 claim 4 , glucosamine claim 4 , an antioxidant claim 4 , insulin claim 4 , a growth factor claim 4 , an antibiotic agent claim 4 , an anti-scarring agent claim 4 , a peptide claim 4 , an analgesic claim 4 , or an antiseptic.10. The device of claim 1 , wherein crosslinked hyaluronic acid has a degree of crosslinking with the crosslinker of between about 0.01% and about ...

Подробнее
14-01-2016 дата публикации

DEPOLYMERISATION OF ALGINIC ACID

Номер: US20160009829A1
Принадлежит:

Depolymerisation of alginic acid by microwave treatment. 1. A method of depolymerisation of alginic acid , said method comprising the steps of:a) providing alginic acid as a starting material for step b, wherein the alginic acid starting material has a pH in the range of 0-4.4 and wherein the dry matter content of the alginic acid starting material is in the range of 5-100% w/w, andb) treating said alginic acid starting material with microwave irradiation to obtain a depolymerised alginic acid material.2. The method according to claim 1 , wherein the microwave frequency is between 300 MHz and 300 GHz claim 1 , such as 300 MHz to 30 GHz claim 1 , preferably 300 MHz to 3 GHz.3. The method according to claim 1 , wherein the concentration of alginic acid in the alginic acid starting material is in the range of 7.5-100% w/w based on dry matter claim 1 , such as in the range of 80-100% w/w based on dry matter claim 1 , preferably in the range of 90-100% w/w based on dry matter.4. The method according to claim 1 , wherein the alginic acid starting material has a pH in the range of 0-3.5.5. The method according to claim 1 , wherein the dry matter content of the alginic acid starting material is in the range of 5-90% w/w.6. The method according to claim 1 , wherein the starting alginic acid material has a weight average molecular weight of 1 claim 1 ,500 claim 1 ,000-50 claim 1 ,000 Da.7. The method according to claim 1 , wherein the alginic acid starting material comprises alginic acid in a mixture with one or more selected solvents from the group consisting of water claim 1 , methanol claim 1 , ethanol claim 1 , and isopropanol.8. The method according to claim 1 , wherein the alginic acid starting material comprises alginic acid in water.9. The method according to claim 1 , wherein the alginic acid starting material further comprises a reducing and/or oxidizing agent.10. The method according to claim 1 , wherein the alginic acid starting material is drained and/or pressed ...

Подробнее
08-01-2015 дата публикации

CHITIN NANOWHISKER COMPOSITES AND METHODS

Номер: US20150011684A1
Автор: Guan Qi
Принадлежит:

A composite includes particles of thermoplastic polymer coated with a chitin nanowhisker gel and melt-blended. The thermoplastic polymer may be polystyrene, polyethylene, acrylonitrile butadiene styrene, polycarbonate, or another thermoplastic polymer. A method of processing chitin includes forming a non-colloidal mixture substantially of chitin and hydrochloric acid to subject the chitin to hydrolysis; upon the mixture becoming substantially colloidal, controlling conditions of the mixture to slow the hydrolysis; dialyzing the substantially colloidal mixture to produce a processed colloidal mixture consisting substantially of water and crystalline chitin; and reducing amount of agglomerated crystalline chitin and water in the processed colloidal mixture thereby to yield chitin nanowhisker gel. A method of forming a composite of chitin nanowhiskers dispersed in a thermoplastic polymer matrix includes coating thermoplastic polymer particles with a chitin nanowhisker gel; and subjecting the coated particles to melt-blending thereby to form the composite. 1. A composite comprising particles of thermoplastic polymer coated with a chitin nanowhisker gel and melt-blended.2. The composite of claim 1 , wherein the chitin nanowhisker gel is 5-10% wt of the thermoplastic polymer.3. The composite of claim 1 , wherein the chitin nanowhiskers are about 20% wt of the gel suspension.4. The composite of claim 1 , wherein the thermoplastic polymer comprises polypropylene.5. The composite of claim 1 , wherein the thermoplastic polymer comprises polyethylene.6. The composite of claim 1 , wherein the thermoplastic polymer comprises acrylonitrile butadiene styrene.7. The composite of claim 1 , wherein the thermoplastic polymer comprises polycarbonate.8. The composite of claim 1 , wherein the composite is comprised of about 1% wt to about 5% wt chitin nanowhiskers.9. The composite of claim 1 , wherein the composite is comprised of about 1% wt chitin nanowhiskers.10. A composite ...

Подробнее
08-01-2015 дата публикации

Method for the manufacture of concentrated aqueous solutions of alkali metal salt of carboxymethyl fructan

Номер: US20150011748A1
Принадлежит: ITALMATCH CHEMICALS SPA

A method is for the manufacture of aqueous solutions of alkali metal salt of carboxymethyl fructan. More specifically the method for the manufacture of aqueous solutions includes at least 20% by weight of alkali metal salt of carboxymethyl fructan having a degree of carboxymethyl substitution of at least 1.2.

Подробнее
14-01-2021 дата публикации

BETA-GLUCAN COMPOSITIONS INCLUDING SURFACTANT

Номер: US20210009892A1
Автор: MALSAM Jeffrey J.
Принадлежит: CARGILL INCORPORATED

Beta-glucan compositions including surfactants and methods of using the same, such as for treatment of subterranean formations. An aqueous beta-glucan composition includes a beta-glucan and a surfactant. 153.-. (canceled)54. An aqueous beta-glucan composition comprising:a beta-glucan that is about 0.001 wt % to about 5 wt % of the composition;one or more surfactants comprising an anionic surfactant that together are about 0.01 wt % to about 5 wt % of the composition; andsalt water that is about 88 wt % to about 99 wt % of the composition; the composition has a total dissolved solids level about 40,000 ppm o about 200,000 ppm,', 'at a temperature of at least one of 52°C. and 92° C., the composition is substantially free of phase separation and haziness according to visual detection for at least about 14 days, and', {'sup': '0', 'at a temperature of at least one of 52° C. and 92 C, and in an emulsion with crude oil, the composition has an oil solubilization ratio of 10 or more, or a water solubilization water of 10 or more, or both.'}], 'wherein'}55. An aqueous beta-glucan composition comprising:scleroglucan that is about 0.04 wt % to about 0.08 wt % of the composition;one or more surfactants comprising an anionic surfactant that together are about 0.5 wt % to about 3 wt % of the composition; andsalt water that is about 97 wt % to about 99 wt % of the composition; the composition has a pH of about 7 to about 8.5,', 'the composition has .a total dissolved solids level of about 46,000 ppm to about 71,000 ppm, and', 'at a temperature of at least one of 52° C. and 92° C., and in an emulsion with crude oil, the composition has an oil solubilization ratio of 10 or more, or a water solubilization water of 10 or more, or both., 'wherein'}56. An aqueous beta-glucan composition comprising:scieroglucan that is about 0.04 wt % to about 0.08 wt % of the composition;one or more surfactants comprising an anionic surfactant that together are about 0.5 wt % to about 3 wt % of the ...

Подробнее
14-01-2021 дата публикации

BACTERIAL CULTURES AND METHODS FOR PRODUCTION OF ALGINATE

Номер: US20210010096A1
Принадлежит:

Bacterial cultures are provided that comprise a modified bacterium missing or deficient in two or more virulence factors. The two or more virulence factors can be selected from exotoxin A, hemolytic phospholipase C, phenazine-specific methyltransferase, alpha-1,3-rhamnosyltransferase, and 3-phosphoshikimate 1-carboxyvinyltransferase. Certain of the modified bacteria are also missing or deficient in one or more alginate acetylation enzymes including the alginate Oacetyltransferases AlgI, AlgJ, AlgF, AlgX, and/or the C5-mannuronan epimerase AlgG. Methods of producing alginate are also provided along with compositions comprising alginate produced by the modified bacteria. 1Pseudomonas aeruginosa. A bacterial culture , comprising a modified bacterium missing or deficient in two or more virulence factors , the two or more virulence factors selected from the group consisting of exotoxin A , hemolytic phospholipase C , phenazine-specific methyltransferase , alpha-1 ,3-rhamnosyltransferase , and 3-phosphoshikimate 1-carboxyvinyltransferase.2Pseudomonas aeruginosa. The bacterial culture of claim 1 , wherein the modified bacterium is missing or deficient in exotoxin A claim 1 , hemolytic phospholipase C claim 1 , phenazine-specific methyltransferase claim 1 , alpha-1 claim 1 ,3-rhamnosyltransferase claim 1 , and 3-phosphoshikimate 1-carboxyvinyltransferase.3Pseudomonas aeruginosa. The bacterial culture of claim 1 , wherein the modified bacterium includes a deletion of two or more virulence factor genes claim 1 , the virulence factor genes selected from toxA claim 1 , plcH claim 1 , phzM claim 1 , wapR claim 1 , aroA claim 1 , and combinations thereof.4Pseudomonas aeruginosa. The bacterial culture claim 1 , wherein the modified bacterium is missing or deficient in one or more alginate acetylation enzymes claim 1 , the one or more alginate acetylation enzymes selected from the group consisting of alginate O-acetyltransferase AlgI claim 1 , alginate O-acetyltransferase AlgJ ...

Подробнее
09-01-2020 дата публикации

GUAR IN MULTICOLOR WATER-BASED PAINT

Номер: US20200010718A1
Принадлежит: Rhodia Operations

Disclosed are novel colorant systems and related method of preparing said systems. Also disclosed are methods of dispersing at least one pigment to prepare a universal colorant system, as well as methods for preparing coatings and paints utilizing the disclosed colorant systems. 2. The composition of wherein the sum of the presented “n” claim 1 , “m” and “p” equals an integer of from 6 to 30.3. The composition of wherein Ris a linear or branched C-Calkyl or alkenyl group claim 1 , or a linear or branched C-Calkyl or alkenyl group claim 1 , or a linear or branched C-Calkyl or alkenyl group claim 1 , or a linear or branched C-Calkyl or alkenyl group claim 1 , or a linear or branched C-Calkyl or alkenyl group claim 1 , or a linear or branched C-Calkyl or alkenyl group.4. The composition of wherein the weight average molecular weight (Mw) of the first dispersing aid is from about 200 g/mole to about 25 claim 1 ,000 g/mole.5. The composition of wherein the weight average molecular weight (Mw) of the first dispersing aid is from about 300 g/mole to about 10 claim 1 ,000 g/mole.6. The composition of wherein the weight average molecular weight (Mw) of the first dispersing aid is from about 300 g/mole to about 5 claim 1 ,000 g/mole.7. The composition of wherein the ratio of “m” to “n+p” (m:(n+p)) is from 1:9 to 9:1 claim 1 , respectively.8. The composition of wherein the ratio of “m” to “n+p” (m:(n+p)) is from 1:4 to 4:1 claim 1 , respectively.9. The composition of wherein the at least one second dispersing aid is least one of a polymeric dispersant claim 1 , polycarboxylate claim 1 , sodium polyacrylate claim 1 , glycol claim 1 , diethylene glycol claim 1 , glycerine claim 1 , C-Calcohol ethoxylate and its sulfate or phosphate salts claim 1 , sorbitan monoleate claim 1 , tristyryl phenol ethoxylate claim 1 , nopol-containing surfactant claim 1 , or eicosa(propoxy)deca(ethoxy)diethylamine.11. The composition of wherein the composition is characterized by a VOC (Volatile ...

Подробнее
03-02-2022 дата публикации

Cross-Linkable Polymer, Hydrogel, and Method of Preparation Thereof

Номер: US20220031909A1

The invention relates to a cross-linkable polymer including a base polymer including functional groups at least some of which have been reacted with a first organic molecule including a cross-linkable unit and with a second organic molecule capable of bonding to organic and/or inorganic substrates. The invention further relates to a hydrogel including the cross-linkable polymer that includes cross-linkable polymer strands, wherein at least some of the cross-linkable units of different cross-linkable polymer strands have reacted to form a covalent bond thereby forming a covalently linked network. The invention further relates to a method for the preparation of the hydrogel and to the use of the hydrogel.

Подробнее
03-02-2022 дата публикации

AMINE FUNCTIONALIZED CHITIN FOR REMOVING MUNITIONS COMPOUNDS FROM SOLUTION

Номер: US20220033530A1
Принадлежит:

The invention is a renewable adsorbent material, amine-functionalized chitin (AFC) that can remove the following munitions compounds from solution while providing a concentration-dependent color change: NTO, DNAN, and TNT. Adsorption of the munitions constituents can be adjusted by pH; neutral pH provides maximum adsorption. NTO can desorb from the AFC at pH levels of 2 and 12; DNAN and TNT remain attached to AFC once adsorbed. 1. A method for forming an amine functionalized chitin compound comprised of the steps of:forming an aqueous chitin sodium hydroxide solution;forming a chloroform tosyl chloride solution; 'wherein said tosyl chitin is comprised of chitin molecules with tosyl molecules bound to said chitin molecules;', 'combining said aqueous chitin sodium hydroxide solution and said chloroform tosyl chloride solution to form a tosyl chitin binding solution that contains tosyl chitin;'}solidifying said tosyl chitin;washing solidified tosyl chitin;filtering said solidified tosyl chitin to extract a quantity of tosyl chitin; 'wherein said DMSO solution includes dimethyl sulfoxide (DMSO) and amine group molecules; and', 'adding said tosyl chitin to a DMSO solution to create an amine group-exposed solution;'}heating said DMSO solution until said tosyl molecules separate from said chitin molecules and said amine group molecules bind to said chitin molecules to create amine functionalized chitin molecules within said DMSO solution.2. The method of claim 1 , wherein said aqueous chitin sodium hydroxide solution is comprised of a volume of water and 500 mg of chitin for each 10 mL volume of water and 4 grams of sodium hydroxide for each 10 mL volume of water.3. The method of claim 1 , wherein said chloroform tosyl chloride solution is comprised of a volume of chloroform and 8.7 grams of tosyl chloride for each 20 mL volume of chloroform.4. The method of claim 1 , wherein the step of combining said aqueous chitin sodium hydroxide solution and said chloroform tosyl ...

Подробнее
03-02-2022 дата публикации

Polysaccharide Derivatives and Compositions Comprising Same

Номер: US20220033531A1
Принадлежит:

The disclosure relates to polysaccharide derivatives comprising a polysaccharide substituted with at least one carbamate group, wherein the polysaccharide comprises poly alpha-1,3-glucan, poly alpha-1,3-1,6-glucan, or a mixture thereof, and the polysaccharide derivative has a degree of substitution of about 0.001 to about 3 with the carbamate group. The disclosure further relates to compositions comprising the polysaccharide derivative, and to a fiber, film, coating, or article comprising the polysaccharide derivative. 1. A polysaccharide derivative comprising:a polysaccharide substituted with at least one carbamate group;wherein the polysaccharide comprises poly alpha-1,3-glucan, poly alpha-1,3-1,6-glucan, or a mixture thereof; andthe polysaccharide derivative has a degree of substitution of about 0.001 to about 3.2. The polysaccharide derivative of claim 1 , wherein the polysaccharide comprises poly alpha-1 claim 1 ,3-glucan claim 1 , and the poly alpha-1 claim 1 ,3-glucan comprises a backbone of glucose monomer units wherein greater than or equal to 50% of the glucose monomer units are linked via alpha-1 claim 1 ,3-glycosidic linkages.3. The polysaccharide derivative of claim 1 , wherein the polysaccharide comprises alpha-1 claim 1 ,3-glucan claim 1 , and the poly alpha-1 claim 1 ,3-glucan comprises a backbone of glucose monomer units wherein greater than or equal to 90% of the glucose monomer units are linked via alpha-1 claim 1 ,3-glycosidic linkages.4. Them polysaccharide derivative of claim 1 , wherein the polysaccharide comprises poly alpha-1 claim 1 ,3-1 claim 1 ,6-glucan claim 1 , wherein (i) at least 30% of the glycosidic linkages of the poly alpha-1 claim 1 ,3-1 claim 1 ,6-glucan are alpha-1 claim 1 ,3 linkages claim 1 , (ii) at least 30% of the glycosidic linkages of the poly alpha-1 claim 1 ,3-1 claim 1 ,6-glucan are alpha-1 claim 1 ,6 linkages claim 1 , (iii) the poly alpha-1 claim 1 ,3-1 claim 1 ,6-glucan has a weight average degree of polymerization ...

Подробнее
03-02-2022 дата публикации

CONJUGATES OF HYALURONIC ACID AND AMINOBISPHOSPHONATES AND THE THERAPEUTIC USE THEREOF

Номер: US20220033623A1
Принадлежит: FIDIA FARMACEUTICI S.p.A.

The present invention describes conjugates of hyaluronic acid (HA) and an amino-bisphosphonate (N-BP) of general formula (I): 2. Conjugate according to claim 1 , wherein m is an integer from 2 to 5.3. Conjugate according to claim 1 , wherein p is 1.4. Conjugate according to claim 1 , wherein n is 2 claim 1 , 3 or 5.5. Conjugate according to claim 1 , wherein both m and n are 2.6. Conjugate according to claim 1 , wherein the weight-average molecular weight of hyaluronic acid ranges from 1×10Da to 1×10Da claim 1 , more preferably from 150000 Da to 800000 Da claim 1 , and even more preferably from 170000 Da to 230000 Da or from 500000 Da to 730000 Da.7. Conjugate according to claim 1 , wherein x ranges from 0.10 to 0.30 mol/mol claim 1 , more preferably from 0.10 to 0.20 mol/mol.8. A conjugate of formula (I) as defined in for use as a medicament.9. Pharmaceutical composition containing a conjugate of formula (I) as defined in claim 1 , and at least one pharmaceutically acceptable excipient and/or carrier.10. A method of intra-articularly and/or locoregionally treating osteoarthrosis and its repercussions at cartilage and subchondral level; treating post-menopausal osteoporosis or osteoporosis induced by drugs; treating bone fragility due to traumas or diseases claim 1 , intraosseously and/or locoregionally treating diseases characterised by altered metabolic bone turnover; and treating and filling of subchondral bone lesion claim 1 , which comprises administering to a patient in need there of the conjugate according to .11. A method of improving osseointegration of prostheses claim 1 , which comprises administering to a patient in need there of the conjugate according to .12. A viscosupplement comprising a conjugate of formula (I) as defined in claim 1 , and at least one pharmaceutically acceptable excipient and/or carrier.13. A method of intra-articularly and/or locoregionally treating osteoarthrosis and its repercussions at cartilage and subchondral level; treating ...

Подробнее
03-02-2022 дата публикации

ALGINATES FOR CORROSION AND SCALE CONTROL

Номер: US20220033704A1
Принадлежит:

Provided herein are methods for inhibiting the formation of scale on equipment in contact with a produced fluid containing a scale-forming divalent cation. Such methods can comprise adding an activated alginate to the produced fluid in an amount effective to react with the divalent cation in the produced fluid to form an activated alginate complex; and separating the activated alginate complex from the produced fluid. Methods can further comprise recycling the activated alginate from the activated alginate complex by dissolving the activated alginate complex. The activated alginate can be prepared by thermally modifying an alginate precursor at a temperature of from 80° C. to 180° C. for a period of at least 24 hours. The activated alginate can be in the form of a solution including 0.1% to 10% by weight activated alginate, based on the total weight of the solution. The activated alginate can exhibit increased solubility in water and kinetics of complexation with the divalent cation compared to the alginate precursor. 1. A method of inhibiting formation of scale on equipment in contact with a produced fluid containing a scale-forming divalent cation , the method comprising:thermally modifying an alginate precursor under conditions effective to afford an activated alginate that dissolves in less than 60 seconds into water and glycol phases at a concentration of 1% by weight at 25° C.;adding the activated alginate to the produced fluid in an amount effective to react with the divalent cation in the produced fluid to form an activated alginate complex; andseparating the activated alginate complex from the produced fluid.2. The method of claim 1 , wherein thermally modifying the alginate precursor is performed in an open container or under inert atmosphere.3. The method of claim 1 , wherein the alginate precursor is thermally modified at a temperature of 80° C. or greater claim 1 , such as 120° C. or greater claim 1 , or 140° C. or greater.4. The method of claim 3 , ...

Подробнее
19-01-2017 дата публикации

Conjugates of Oligomer of Hyaluronic Acid or of a Salt Thereof, Method of Preparation Thereof and Use Thereof

Номер: US20170015759A1
Принадлежит:

The invention relates to conjugates of hyaluronic acid oligomer according to the general formulae I, II III or IV, or a salt thereof, the method of preparation thereof and use thereof, where the oligomer is bonded to the respective substrate by its ending anomeric center via a bi-functional amino linker by means of an amino or imino bond. This type of conjugates allows releasing oligomers in their native form. The prepared systems exhibited an enhanced biological activity against selected lines of cancer cells. 2. The conjugate according to claim 1 , characterized by that the polysaccharide is selected from the group comprising hyaluronic acid or a pharmaceutically acceptable salt thereof.3. The conjugate according to claim 2 , characterized by that hyaluronic acid or the pharmaceutically acceptable salt thereof has the molecular weight within the range of 10to 10g·mol claim 2 , preferably 10g·mol.4. The conjugate according to claim 1 , characterized by that the hyaluronic acid oligomer residue comprises 1 to 17 saccharidic cycles claim 1 , wherein the saccharidic cycle is selected from the group consisting of β-(1 claim 1 ,3)-D-glucuronic acid and β-(1 claim 1 ,4)-N-acetyl-D-glucosamine.6. The method of preparation according to claim 5 , characterized by that the hyaluronic acid oligomer residue comprises 1 to 17 saccharidic cycles claim 5 , wherein the saccharidic cycle is selected from the group consisting of β-(1 claim 5 ,3)-D-glucuronic acid and β-(1 claim 5 ,4)-N-acetyl-D-glucosamine.7. The method of preparation according to claim 5 , characterized by that the substrate is a polysaccharide claim 5 , preferably selected from the group comprising hyaluronic acid or a pharmaceutically acceptable salt thereof.8. The method according to claim 7 , characterized by that hyaluronic acid or the pharmaceutically acceptable salt thereof has the molecular weight within the range of 10to 10g·mol claim 7 , preferably 10g·mol.9. The method of preparation according to claim 5 ...

Подробнее
17-01-2019 дата публикации

Use of a Polyanionic Composition

Номер: US20190015514A1
Принадлежит:

Disclosed herein is a use of a composition, comprising a non-toxic polyanionic material or a salt thereof to dissociate a polymeric membrane. In addition, a method of dissociating a polymeric membrane is also presented, the method comprising the steps of providing a polymeric membrane; and dissociating the polymeric membrane by adding a composition comprising a non-toxic polyanionic material to the polymeric membrane. 1. Use of a composition comprising a non-toxic polyanionic material or a salt thereof to dissociate a polymeric membrane , wherein the non-toxic polyanionic material is a polysaccharide sulfate , a poly(sodium styrene sulfonate) or a polyacrylic acid or a salt thereof , provided that the polysaccharide sulfate is not a glycosoaminoglycan.2. The use of claim 1 , wherein the polymeric membrane is in the form of a capsule that encapsulates a substance or in the form of a barrier that blocks free movement of a substance.3. The use of or claim 1 , wherein the polymeric membrane comprises sodium cellulose sulfate and polydiallyldimethylammonium chloride (pDADMAC).4. The use of or claim 1 , wherein the substance is selected from one or more of the group consisting of cells claim 1 , proteins claim 1 , biocompatible particles claim 1 , and chemical compounds claim 1 , optionally wherein the substance is a plurality of cells.5. The use of any one of the preceding claims claim 1 , wherein the polyanionic material or a salt thereof has a number average molecular weight of from 4 claim 1 ,000 to 20 claim 1 ,000 Daltons claim 1 , optionally from 4 claim 1 ,500 to 15 claim 1 ,000 Daltons (e.g. from 5 claim 1 ,000 to 10 claim 1 ,000 Daltons claim 1 , such as 5 claim 1 ,000 Daltons).6. The use of any one of the preceding claims claim 1 , wherein the polyanionic material or salt thereof is a polysaccharide sulfate claim 1 , optionally wherein each saccharide unit of the polysaccharide sulfate contains from 1 to 3 sulfate groups.7. The use of claim 6 , wherein the ...

Подробнее
17-01-2019 дата публикации

METHOD FOR PREPARING HIGH-FUNCTIONAL SUTURE YARN COATED WITH HYALURONATE AND HIGH-FUNCTIONAL SUTURE YARN PREPARED THEREFROM

Номер: US20190015544A1
Принадлежит:

Provided are a method of manufacturing a hyaluronate-coated high-functional suture and a high-functional suture manufactured thereby, and more particularly to a method of manufacturing a high-functional suture and a high-functional suture manufactured thereby, wherein a suture for internal and external surgery derived from a conventional chemical synthetic material is coated with a hyaluronate as a biocompatible material, thus improving biocompatibility, functionality and ease of use. 1. A method of manufacturing a hyaluronate-coated suture , comprising the steps of:(a) preparing a hyaluronate organic-solvent aqueous solution having an organic solvent concentration of 50˜70 vol % and a hyaluronate concentration of 0.5˜2 vol % by dissolving a hyaluronate in purified water and then adding an organic solvent thereto; and(b) coating a suture with the hyaluronate organic-solvent aqueous solution and then drying the suture.2. The method of claim 1 , wherein the hyaluronate of the hyaluronate organic-solvent aqueous solution has a weight average molecular weight of 5˜100 kDa.3. The method of claim 1 , wherein the suture is an absorbable suture or a non-absorbable suture.4. The method of claim 1 , wherein the coating is performed by immersing the suture in the hyaluronate organic-solvent aqueous solution or spraying the hyaluronate organic-solvent aqueous solution onto the suture.5. A hyaluronate-coated suture claim 1 , manufactured by the method of .6. A filler for cosmetic surgery claim 5 , comprising the hyaluronate-coated suture of .7. A lifting thread claim 5 , comprising the hyaluronate-coated suture of .8. A tissue-engineering scaffold claim 5 , comprising the hyaluronate-coated suture of . The present invention relates to a method of manufacturing a hyaluronate-coated high-functional suture and a high-functional suture manufactured thereby, and more particularly to a method of manufacturing a high-functional suture and a high-functional suture manufactured thereby, ...

Подробнее
21-01-2016 дата публикации

ANTIBODIES TARGETED TO FUNGAL CELL WALL POLYSACCHARIDES

Номер: US20160017062A1
Принадлежит: Wellstat Vaccines, LLC

A compound comprising one or more polysaccharide moieties each independently represented by the formula β(1→4)-[GlcNH—R]-2,5-anhydromannose, wherein n is a positive integer from 3 to 500, and R is H or an acyl group, is described. The compound can be manufactured by (a) reacting chitosan with an acylating agent sufficient to partially N-acylate the chitosan, yielding a modified chitin/chitosan mixed polymer; and (b) reacting the modified chitin/chitosan mixed polymer with a deaminating agent to cleave the mixed polymer at the unacylated chitosan moieties. The compound can be used to immunize against fungal infection. Antibodies specific to the compound, and the use of such antibodies to protect against fungal infection are also described.

Подробнее
18-01-2018 дата публикации

CHITIN, HYDROLYSATE AND METHOD FOR THE PRODUCTION OF ONE OR MORE DESIRED PRODUCTS FROM INSECTS BY MEANS OF ENZYMATIC HYDROLYSIS

Номер: US20180016357A1
Принадлежит: YNSECT

The invention relates to chitin, a hydrolysate and a method for the production of at least one desired product from insects. More specifically, the invention relates to a method for the production of at least one desired product from insects, comprising an insect cuticle pressing step, followed by the enzymatic hydrolysis of the insect cuticles using a proteolytic enzyme. 1. Chitin comprising an amino acid content less than or equal to 45% by weight based on the total weight of dry matter , an ash content less than or equal to 3.5% by weight based on the total weight of dry matter and a purity by difference greater than or equal to 45%.2. Hydrolysate comprising at least 40% by weight proteins based on the total weight of dry matter , at a maximum 10% by weight ash based on the total weight of dry matter , and a water-soluble protein content larger than 12 ,400 g/mol less than 50%.3. Method for the production of at least one product of interest from insects , comprising the following steps:(i) grinding the insect cuticles,(ii) pressing the insect cuticles, and then(iii) enzymatic hydrolysis of the insect cuticles with a proteolytic enzyme.4. Method according to claim 3 , comprising a step of killing the insects prior to the grinding step.5. Method according to or claim 3 , further comprising a step of treatment of the insect cuticles with an oxidizing agent prior to enzymatic hydrolysis.6. Method according to any one of to claim 3 , in which the insect or insects is/are selected from the group constituted by the Coleoptera claim 3 , the Lepidoptera claim 3 , the Orthoptera and the Diptera.7. Method according to any one of to claim 3 , in which the protease is selected from the group constituted by aminopeptidases claim 3 , metallocarboxypeptidases claim 3 , serine endopeptidases claim 3 , cysteine endopeptidases claim 3 , aspartic endopeptidases claim 3 , metalloendopeptidases.8. Method according to any one of to claim 3 , in which the product of interest is chitin ...

Подробнее
15-01-2015 дата публикации

CHITOSAN-DERIVED COMPOSITIONS

Номер: US20150018748A1
Принадлежит: IMMUNOPHOTONICS, INC.

The present invention relates generally to therapeutic compositions comprising chitosan-derived compositions used in connection with methods for treating neoplasms, such as for instance, malignant lung, thyroid and kidney neoplasms, and other types of malignant neoplasms, and other medical disorders. 1. A viscoelastic glycated chitosan formulation , consisting essentially of glycated chitosan polymer , wherein the glycated chitosan polymer has a molecular weight between about 50 ,000 Daltons to about 1 ,500 ,000 Daltons , and further wherein the degree of glycation of free amino groups of the chitosan polymer ranges from about one tenth of one percent to about thirty percent.2. The viscoelastic glycated chitosan formulation of claim 1 , wherein the molecular weight of the viscoelastic glycated chitosan is approximately 250 claim 1 ,000 Daltons claim 1 , the degree of deacetylation of a chitin parent of the viscoelastic glycated chitosan is about eighty percent claim 1 , and the degree of glycation of free amino groups of the chitosan is about seven percent.3. The viscoelastic glycated chitosan formulation of claim 1 , wherein the glycated chitosan polymer possesses about two percent glycation of its otherwise free amino groups.4. The viscoelastic glycated chitosan formulation of claim 1 , wherein the final viscoelastic formulation is formulated as an aqueous solution possessing a pH from between about five (5) to about seven (7).5. The viscoelastic glycated chitosan formulation of claim 1 , wherein the viscoelastic formulation is formulated as an aqueous solution comprising a buffered physiological saline solution.6. The viscoelastic glycated chitosan formulation of claim 1 , wherein the viscoelastic formulation comprises about one percent by weight of the glycated chitosan polymer dispersed in an aqueous solution claim 1 , said aqueous solution having a viscosity of between about one to about one hundred centistokes measured at about 25 degrees Celsius.7. The ...

Подробнее
16-01-2020 дата публикации

METHOD FOR MANUFACTURING HYALURONATE FILM, AND HYALURONATE FILM MANUFACTURED THEREBY

Номер: US20200016795A1
Принадлежит:

The present invention relates to a method of manufacturing a hyaluronate film and a hyaluronate film manufactured thereby, and more particularly to a method of manufacturing a hyaluronate film through a solvent-casting process or using an automatic film applicator that facilitates mass production and to a hyaluronate film manufactured thereby, which is useful as a mask pack for cosmetics, a patch for medicaments and medical devices, a film-type adhesion inhibitor, etc. Unlike conventional liquid products, the hyaluronate film according to the present invention has a dry surface and thus entails no concern about microbial contamination, is easy to produce/manage/distribute/use, and has superior mechanical properties, whereby it can be utilized for various applications such as packs, patches, artificial skin and the like for cosmetics, medicaments, and medical devices. 1. A method of manufacturing a hyaluronate film , the method comprising:(a) preparing a hyaluronate solution by dissolving hyaluronate in a solvent; and(b) drying the hyaluronate solution through a solvent-casting process or a casting process using an automatic film applicator.2. The method of claim 1 , wherein the solvent-casting process includes:(a) preparing a 0.1 to 30 wt % hyaluronate solution by dissolving hyaluronate in a solvent; and(b) placing the hyaluronate solution in a mold and drying the hyaluronate solution under conditions of a relative humidity of 30 to 70% and a drying temperature of 30 to 50° C.3. The method of claim 2 , wherein the hyaluronate has a molecular weight of 0.1 to 2.5 MDa.4. The method of claim 2 , wherein the solvent is water or a 0.01 to 29 vol % ethanol aqueous solution.5. The method of claim 2 , wherein the drying the hyaluronate solution is performed using a constant-temperature and constant-humidity chamber.6. The method of claim 1 , wherein the casting process using the automatic film applicator includes:(a) preparing a 0.1 to 30 wt % hyaluronate solution by ...

Подробнее
16-01-2020 дата публикации

PROCESSES FOR MAKING CHITOSAN SALTS AND PRODUCTS FORMED THEREBY

Номер: US20200017608A1
Принадлежит: PRIMEX EHF.

The present disclosure generally relates to improved processes for making chitosan salts and products formed by such processes. In certain embodiments, the processes disclosed herein provide the ability to make high-grade chitosan salts at lower cost and with improved environmental friendliness. 1. A method for making a chitosan salt , comprising:providing a chitosan composition, which comprises chitosan;combining the chitosan composition with water and one or more acids to form a hydrated chitosan composition; andremoving at least a portion of the water from the hydrated chitosan composition to form a dried chitosan salt composition, which comprises chitosan salt.2. The method of claim 1 , wherein the chitosan composition comprises at least 75 weight percent claim 1 , or at least 80 weight percent claim 1 , or at least 85 weight percent claim 1 , or at least 90 weight percent claim 1 , or at least 95 weight percent claim 1 , or at least 97 weight percent claim 1 , or at least 99 weight percent claim 1 , chitosan claim 1 , based on the total weight of solids in the composition.3. The method of claim 2 , wherein the chitosan comprises at least 75 weight percent claim 2 , or at least 80 weight percent claim 2 , or at least 85 weight percent claim 2 , or at least 90 weight percent claim 2 , or at least 95 weight percent claim 2 , or at least 97 weight percent claim 2 , or at least 99 weight percent claim 2 , chitosan of crustacean origin claim 2 , based on the total weight of chitosan in the composition.4. The method of claim 2 , wherein the chitosan has an apparent viscosity ranging from 20 cP to 200 claim 2 ,000 cP claim 2 , or from 30 cP to 10 claim 2 ,000 cP claim 2 , or from 40 cP to 2 claim 2 ,000 cP.5. The method of claim 2 , wherein the chitosan has weight-average molecular weight ranging from 100 kDa to 2 claim 2 ,000 kDa.6. The method of claim 2 , wherein the chitosan has a degree of deacetylation (DDA) of at least 60%.7. The method of claim 1 , wherein the ...

Подробнее
16-01-2020 дата публикации

WATER-SOLUBLE AND/OR WATER-SWELLABLE HYBRID POLYMER

Номер: US20200017619A1
Принадлежит: CLARIANT INTERNATIONAL LTD.

A water-soluble and/or water-swellable hybrid polymer comprising: 2. The water-soluble and/or water-swellable hybrid polymer according to claim 1 , wherein the monomers resulting in units (a) claim 1 , (b) claim 1 , (c) and/or (d) are/is neutralized with a base prior to the polymerization claim 1 , and/or the hybrid polymer after polymerization is neutralized with a base.3. The water-soluble and/or water-swellable hybrid polymer according to claim 2 , wherein the base is selected from bases comprising an ion selected from the group consisting of Li claim 2 , Na claim 2 , K claim 2 , Ca claim 2 , Mg claim 2 , ZnAland combinations thereof.4. The water-soluble and/or water-swellable hybrid polymer according to claim 1 , wherein the repeating units according to Formula (1) result from the incorporation of a monomer selected from the group consisting of acryloyldimethyltaurates claim 1 , acryloyl-1 claim 1 ,1-dimethyl-2-methyltaurates claim 1 , acryloyltaurates claim 1 , acryloyl-N-methyltaurates claim 1 , and combinations thereof.7. The water-soluble and/or water-swellable hybrid polymer according to claim 1 , wherein the hybrid polymer comprises at least 30 wt.-% polysaccharide polymer claim 1 , by total weight of the hybrid polymer.8. The water-soluble and/or water-swellable hybrid polymer according to claim 1 , wherein the crosslinking or branching units result from the incorporation of a crosslinker selected from the group consisting of methylenebisacrylamide; methylenebismethacrylamide; esters of unsaturated monocarboxylic and polycarboxylic acids with polyols claim 1 , allyl esters of phosphoric acid; and vinylphosphonic acid derivatives.9. The water-soluble and/or water-swellable hybrid polymer according to claim 1 , wherein the polysaccharide polymer is selected from the group consisting of xanthan gum claim 1 , carrageenan claim 1 , guar gum claim 1 , chitosan and alginate.10. The water-soluble and/or water-swellable hybrid polymer according to claim 1 , ...

Подробнее
21-01-2021 дата публикации

System for Environmental Microbial Testing

Номер: US20210017481A1
Автор: Perlman Daniel
Принадлежит:

A gelled biological growth medium in a culture container, as well as kits and methods of producing the growth medium, utilize gelling of a liquid growth medium containing low methoxyl pectin on a film of calcium salt deposited on a growth surface of the culture container. The salt acts as a trigger for gelation and is conveniently deposited on the walls by evaporation of methanol or another volatile solvent. 1. A kit for preparing a gelled growth medium , the kit comprising:a) a liquid growth medium comprising a low methoxyl pectin material having less than about 8% methoxyl content; andb) a container for culturing microorganisms, wherein the container comprises a calcium lactate precipitate on a growth surface of the container.2. The kit of claim 1 , further comprising:c) instructions for coating the calcium lactate precipitate with a liquid growth medium to form a gelled biological growth medium.3. The kit of claim 1 , wherein the liquid growth medium is selected from the group consisting of potato dextrose broth claim 1 , yeast extract dextrose broth claim 1 , and combinations thereof.4. The kit of claim 1 , wherein the liquid growth medium further comprises an antibacterial agent.5. The kit of claim 4 , wherein the liquid growth medium comprises from about 50 to about 100 micrograms per milliliter of chloramphenicol as the antibacterial agent.6. The kit of claim 1 , wherein the container is a Petri dish.7. The kit of claim 1 , wherein the container for culturing microorganisms comprises from about 50 to about 350 mg of calcium lactate per gram of low methoxyl pectin in the liquid growth medium.8. The kit of claim 1 , which is suitable for preparing a gelled growth medium for selective growth of yeast or mold.9. A kit for preparing a gelled growth medium claim 1 , the kit comprising:a) a liquid growth medium comprising a low methoxyl pectin material having less than about 8% methoxyl content;b) a solution comprising calcium lactate and methanol; andc) a container ...

Подробнее
17-04-2014 дата публикации

Aryl/Alkyl Succinic Anhydride Hyaluronan Derivatives

Номер: US20140106411A1
Принадлежит: NOVOZYMES BIOPHARMA DK A/S

The present invention relates to the modification of hyaluronic acid (HA) with aryl/alkyl succinic anhydrides (ASA) to produce aryl/alkyl succinic anhydride HA derivatives, to the derivatives as such, and to their applications and uses, particularly in the cosmetic and biomedical industries. The ASA-HA derivatives are expected to have interesting properties that can be used for advanced formulation (bind stronger to the skin compared to non-modified HA), possibly also in delivery systems for actives or drugs by encapsulation (nano/micro capsules) or formation of nano/micro spheres. Further, the low MW ASA-HA derivatives are expected to penetrate the skin more efficiently than non-modified HA of the same MW. 2. The process of claim 1 , wherein one of the R1 claim 1 , R2 claim 1 , R3 claim 1 , and R4 groups is an alkyl-succinic acid of formula (II).3. The process of claim 1 , wherein two of the R1 claim 1 , R2 claim 1 , R3 claim 1 , and R4 groups are an alkyl-succinic acid of formula (II).4. The process of claim 1 , wherein three of the R1 claim 1 , R2 claim 1 , R3 claim 1 , and R4 groups are an alkyl-succinic acid of formula (II).5. The process of claim 1 , wherein at least one of the R1 claim 1 , R2 claim 1 , R3 claim 1 , and R4 groups is an alkyl-succinic acid of formula (II) claim 1 , wherein the alkyl group is a C-Calkyl group.6. The process of claim 1 , wherein at least one of the R1 claim 1 , R2 claim 1 , R3 claim 1 , and R4 groups is an alkyl-succinic acid of formula (II) claim 1 , wherein the alkyl group is a propyl claim 1 , 2-octenyl claim 1 , 2-dodecenyl claim 1 , 2-hexadecenyl claim 1 , or 2-octadecenyl group.7. The process of claim 1 , wherein one of the R1 claim 1 , R2 claim 1 , R3 claim 1 , and R4 groups is an aryl-succinic acid of formula (II).8. The process of claim 1 , wherein two of the R1 claim 1 , R2 claim 1 , R3 claim 1 , and R4 groups are an aryl-succinic acid of formula (II).9. The process of claim 1 , wherein three of the R1 claim 1 , R2 ...

Подробнее
10-02-2022 дата публикации

CROSSLINKED HYALURONIC ACID, HYALURONIC ACID HYDROGEL, AND METHOD FOR PRODUCING CROSSLINKED HYALURONIC ACID AND HYALURONIC ACID HYDROGEL

Номер: US20220040374A1
Принадлежит: HANMI PHARM. CO., LTD

Provided are a crosslinked hyaluronic acid product in the form of powder and a method of preparing the same, and a crosslinked hyaluronic acid hydrogel prepared using the crosslinked hyaluronic acid product in the form of powder, and a method of preparing the same. The crosslinked hyaluronic acid hydrogel according to the present disclosure exhibits excellent rheological properties, and mass production thereof is easy and quality uniformity thereof is excellent. 1. A method of preparing a crosslinked hyaluronic acid product in the form of powder , the method comprising:preparing an aqueous solution comprising hyaluronic acid, a salt thereof, or a mixture thereof;adding a crosslinking agent to the aqueous solution to cause a crosslinking reaction of the hyaluronic acid to occur; andadding ethanol to the aqueous solution to solidify the hyaluronic acid into particles.2. The method of claim 1 , wherein claim 1 , when ethanol is added to the aqueous solution claim 1 , the ethanol is added at a rate of 20 mL/min to 1000 mL/min.3. The method of claim 1 , wherein claim 1 , when ethanol is added claim 1 , a rate of volume change of ethanol with respect to the total volume of the mixed solution is 0.5% (v/v)/min to 35% (v/v)/min.4. The method of claim 1 , wherein the crosslinking agent is comprised in an amount of 10 μL to 500 μL with respect to 1 g of hyaluronic acid claim 1 , a salt thereof claim 1 , or a mixture thereof.5. The method of claim 1 , wherein a volume ratio of the aqueous solution and ethanol added to the aqueous solution is 1:1 to 10.6. The method of claim 1 , further comprising a crosslinking reaction of the aqueous solution comprising hyaluronic acid particles.7. The method of claim 1 ,further comprising washing the prepared crosslinked hyaluronic acid product with ethanol or a solution comprising ethanol.8. A crosslinked hyaluronic acid product in the form of powder claim 1 , prepared according to the method of .9. The crosslinked hyaluronic acid product ...

Подробнее
24-01-2019 дата публикации

WATER-SOLUBLE HYDROGEL-BASED DENTAL COMPOSITION AND METHODS OF MAKING AND USING SAME

Номер: US20190021957A1
Принадлежит: DENTSPLY SIRONA Inc.

Described herein are dental compositions, more particularly water soluble dental varnish composition useful for effective fluoridation, in situ biomimetic remineralization and improved adhesion to enamel. The dental composition includes a hydrogel-forming polymer having cohesive properties to itself and adhesive properties to a dental enamel. The hydrogel forming polymer includes a water-soluble polymer and an adhesion promotor chemically and/or physically conjugated to the water-soluble polymer. The embodiments also provide methods of forming a hydrogel forming polymer and use of hydrogel forming polymer to prepare such dental composition. 1. A method of forming a hydrogel-forming polymer having cohesive properties to itself and adhesive properties to dental enamel comprising conjugating an adhesion promoter to a water-soluble polymer in a presence of an antioxidant to form the hydrogel-forming polymer having cohesive properties to itself and adhesive properties to dental enamel , wherein the antioxidant prevents discoloration of the hydrogel-forming polymer having cohesive properties to itself and adhesive properties to dental enamel during the conjugating.2. The method according to claim 1 , wherein the water-soluble polymer contains at least one functional group selected from the group consisting of carboxylic acid claim 1 , amine claim 1 , hydrazide claim 1 , thiol claim 1 , acrylic claim 1 , methacrylic claim 1 , and acrylamide.3. The method according to claim 1 , wherein the adhesion promotor contains at least one functional group selected from the group consisting of amine claim 1 , carboxylic acid claim 1 , thiol claim 1 , acrylic claim 1 , methacrylic claim 1 , and acrylamide group.4. The method according to claim 1 , wherein conjugating the adhesion promoter to the water-soluble polymer occurs through an amidation reaction in an aqueous solution using a carbodiimide catalysis system in presence of a co-catalyst to form a reaction solution.5. The method ...

Подробнее
24-01-2019 дата публикации

INJECTABLE MONOPHASE HYDROGELS

Номер: US20190022130A1
Автор: Lebreton Pierre F.
Принадлежит:

An injectable monophase hydrogel is provided that is made of a reaction mixture of hyaluronic acids having different molecular weights. 1. An injectable composition comprising a hyaluronic acid gel , the hyaluronic acid gel comprising:about 5% by weight to about 50% by weight of a first hyaluronic acid having an average molecular weight in the range of about 1.1×106 Da to about 5×106 Da; andabout 50% by weight to about 95% by weight of a second hyaluronic acid having an average molecular weight in the range of about 1×104 Da to about 9.9×105 Da;wherein the hyaluronic acid gel is crosslinked via covalent bonding between a bifunctional crosslinker and hydroxyl moieties of the first and second hyaluronic acids.2. The injectable composition of claim 1 , wherein the hyaluronic acid gel comprises about 5% by weight to about 30% by weight of the first hyaluronic acid.3. The injectable composition of claim 1 , wherein the hyaluronic acid gel comprises about 70% by weight to about 95% by weight of the second hyaluronic acid.4. The injectable composition of claim 1 , wherein the bifunctional crosslinker is selected from the group consisting of bifunctional crosslinking agents epichlorohydrin claim 1 , divinyl sulfone claim 1 , 1 claim 1 ,4-bis(2 claim 1 ,3-epoxypropoxy)butane claim 1 , 1 claim 1 ,4-bisglycidoxybutane claim 1 , 1 claim 1 ,4-butanediol diglycidyl ether (BDDE)) claim 1 , 1 claim 1 ,2-bis(2 claim 1 ,3-epoxypropoxy)ethylene claim 1 , 1-(2 claim 1 ,3-epoxypropyl)-2 claim 1 ,3-epoxycyclohexane claim 1 , formaldehyde claim 1 , glutaraldehyde claim 1 , and crotonaldehyde.5. The injectable composition of claim 4 , wherein the bifunctional crosslinker is (BDDE).6. The injectable composition of having a concentration of hyaluronic acid gel of between 10 and 40 mg/g.7. The injectable composition of having a concentration of hyaluronic acid gel of between 20 and 30 mg/g.8. The injectable composition of having a concentration of hyaluronic acid gel of 26 mg/g.9. The ...

Подробнее
17-04-2014 дата публикации

OILY COSMETIC

Номер: US20140107228A1
Автор: TOGASHI Shunsuke
Принадлежит: Tokiwa Coporation

[Problems to be solved] In an oily cosmetic product using a filling extrusion container which is used by extruding a filling from a cylindrical storage portion to a tip of ejection portion, an oily cosmetic having smooth usability, excellent makeup durability and temperature stability, and good ejection performance is provided. 1. An oily cosmetic comprising;(a) dextrin palmitate of 5 to 40 weight % wherein an acyl group substitution degree of the dextrin palmitate is less than 2.0,', 'wherein the oily cosmetic is used in a filling extrusion container, and', 'wherein the filling extrusion container is used by extruding a filling from a filling storage portion to a tip of ejection portion., '(b) a volatile hydrocarbon oil of 15 to 65 weight %'}2. The oily cosmetic according to claim 1 ,wherein a content of a solid oil having a melting point of 60° C. or higher is 2 weight % or less.3. The oily cosmetic according to claim 1 ,wherein, in the filling extrusion container, an inner diameter of the tip hole of the ejection portion is smaller than an inner diameter of the storage portion.4. The oily cosmetic according to claim 2 ,wherein, in the filling extrusion container, an inner diameter of the tip hole of the ejection portion is smaller than an inner diameter of the storage portion. 1. Field of the InventionThe present invention relates to an oily cosmetic and an oily cosmetic product, which are used to be filled and stored in a filling extrusion container. The filling extrusion container is used by extruding a filling from a filling storage portion to a tip of ejection portion. The oily cosmetic has smooth usability, excellent makeup durability and temperature stability, and good ejection performance from the container. The oily cosmetic has also properties that there is no liquid leakage and dripping.2. Description of the Conventional ArtConventionally, the oily cosmetic includes, as base materials, an oil component containing solid oil and powders such as pigments, ...

Подробнее
25-01-2018 дата публикации

OXIDIZED DEXTRAN

Номер: US20180022834A1
Принадлежит:

Compositions comprising oxidized dextran compounds are disclosed herein. Oxidized dextran compounds are produced by contacting dextran under aqueous conditions with at least one N-oxoammonium salt, at least one periodate compound, and/or at least one peroxide compound. 1. A composition comprising an oxidized dextran compound , wherein the oxidized dextran compound is produced by contacting dextran under aqueous conditions with at least one N-oxoammonium salt , at least one periodate compound , and/or at least one peroxide compound ,wherein the dextran comprises:(i) about 87-93 wt % glucose linked at positions 1 and 6;(ii) about 0.1-1.2 wt % glucose linked at positions 1 and 3;(iii) about 0.1-0.7 wt % glucose linked at positions 1 and 4;(iv) about 7.7-8.6 wt % glucose linked at positions 1, 3 and 6; and (a) positions 1, 2 and 6, or', '(b) positions 1, 4 and 6;, '(v) about 0.4-1.7 wt % glucose linked atand wherein the weight-average molecular weight (Mw) of the dextran is about 50-200 million Daltons and the z-average radius of gyration of the dextran is about 200-280 nm.2. The composition of claim 1 , wherein the dextran comprises:(i) about 89.5-90.5 wt % glucose linked at positions 1 and 6;(ii) about 0.4-0.9 wt % glucose linked at positions 1 and 3;(iii) about 0.3-0.5 wt % glucose linked at positions 1 and 4;(iv) about 8.0-8.3 wt % glucose linked at positions 1, 3 and 6; and (a) positions 1, 2 and 6, or', '(b) positions 1, 4 and 6., '(v) about 0.7-1.4 wt % glucose linked at3. The composition of claim 1 , wherein the dextran comprises chains linked together within a branching structure claim 1 , wherein said chains are similar in length and comprise substantially alpha-1 claim 1 ,6-glucosidic linkages.4. The composition of claim 3 , wherein the average length of the chains is about 10-50 monomeric units.5. The composition of claim 1 , wherein the dextran is a product of a glucosyltransferase enzyme comprising an amino acid sequence that is at least 90% identical to ...

Подробнее
10-02-2022 дата публикации

Method for producing low-cost fully biodegradable disposable straw

Номер: US20220041865A1

A method for producing a low-cost fully biodegradable disposable straw. Natural plant powder is prepared. Deacetylated konjac gel is prepared. The taro starch-cassava starch is crosslinked. The raw material is stirred and mixed to obtain the mixed raw material, and the mixed raw material is heated. The heated raw material is added to the beverage straw manufacturing unit to obtain a straw crude. The straw crude is cut to obtain several straws. The quality inspection, the disinfection and the packaging of the straw are carried out, and the fully biodegradable straw is obtained, finally.

Подробнее
24-01-2019 дата публикации

CARBOHYDRATE CROSSLINKER

Номер: US20190023812A1
Принадлежит: GALDERMA S.A.

The invention relates to a hydrogel product comprising glycosaminoglycan molecules as the swellable polymer, wherein the glycosaminoglycan molecules are covalently crosslinked via crosslinks comprising a spacer group selected from the group consisting of di-, tri-, tetra-, and oligosaccharides. 1. A hydrogel product comprising glycosaminoglycan molecules as the swellable polymer , wherein the glycosaminoglycan molecules are covalently crosslinked via crosslinks consisting essentially of a spacer group selected from the group consisting of di- , tri- , tetra- , and oligosaccharides , wherein the crosslinked glycosaminoglycan molecules are preferably free , or essentially free from synthetic non-carbohydrate structures or linkers.2. A hydrogel product according to claim 1 , wherein the glycosaminoglycan molecules are hyaluronic acid.3. A hydrogel product according to claim 1 , wherein at least 75% of the crosslinks comprise a spacer group selected from the group consisting of di- claim 1 , tri- claim 1 , tetra- claim 1 , and oligosaccharides.4. A hydrogel product according to claim 1 , wherein the spacer group is a hyaluronic acid tetrasaccharide claim 1 , hyaluronic acid hexasaccharide claim 1 , trehalose claim 1 , lactose claim 1 , maltose claim 1 , sucrose claim 1 , cellobiose or raffinose residue.5. A hydrogel product according to claim 1 , wherein the spacer group is selected from the group consisting of di- claim 1 , tri- claim 1 , and tetrasaccharides.6. A hydrogel product according to claim 1 , wherein at least 90% of the bonds between glycosaminoglycan molecules and crosslinks are amide bonds.7. A hydrogel product according to claim 1 , wherein less than 5% of the bonds between glycosaminoglycan molecules and crosslinks are ester bonds.8. A hydrogel product according to claim 1 , in the form of an injectable formulation.9. A process of preparing a hydrogel product comprising crosslinked glycosaminoglycan molecules claim 1 , comprising the steps of:(a) ...

Подробнее
28-01-2021 дата публикации

NOVEL REACTIVE ALGINIC ACID DERIVATIVES

Номер: US20210024659A1
Принадлежит: MOCHIDA PHARMACEUTICAL CO., LTD.

The present invention provides alginic acid derivatives having a group represented by general formula (I) or general formula (II) (the right side of the dashed line is excluded in each formula) at a portion of the carboxyl groups in an alginic acid. Novel alginic acid derivatives are thereby provided. 9. The alginic acid derivative claim 1 , ester or salt according to wherein the introduction rate of the group represented by formula (I) is 1% to 30%.10. The alginic acid derivative claim 1 , ester or salt according to claim 1 , wherein the weight-average molecular weight as measured by gel filtration chromatography of the alginic acid derivative is 100 claim 1 ,000 Da to 3 claim 1 ,000 claim 1 ,000 Da.12. The alginic acid derivative claim 11 , ester thereof claim 11 , or salt thereof according to claim 11 , wherein Pin formula (II) is a hydrogen atom claim 11 , acetyl group or benzoyl group.16. The alginic acid derivative claim 11 , ester thereof claim 11 , or salt thereof according to claim 11 , wherein the introduction rate of the group represented by formula (II) is 1% to 30%.17. The alginic acid derivative claim 11 , ester thereof claim 11 , or salt thereof according to wherein the weight-average molecular weight as measured by gel filtration chromatography of the alginic acid derivative is 100 claim 11 ,000 Da to 3 claim 11 ,000 claim 11 ,000 Da.18. A composition containing an alginic acid derivative claim 11 , ester thereof claim 11 , or salt thereof according to and an alginic acid derivative according to .19. A crosslinked alginic acid structure obtained by subjecting an alginic acid derivative claim 11 , an ester thereof claim 11 , or a salt thereof according to and an alginic acid derivative according to to a crosslinking reaction.20. A medical material containing the crosslinked alginic acid structure according to .21. The medical material according to claim 20 , wherein the crosslinked alginic acid structure is a bead or a nearly spherical gel.22. A ...

Подробнее
04-02-2016 дата публикации

MODIFIED ALGINATES FOR ANTI-FIBROTIC MATERIALS AND APPLICATIONS

Номер: US20160030360A1
Принадлежит:

Covalently modified alginate polymers, possessing enhanced biocompatibility and tailored physiochemical properties, as well as methods of making and use thereof, are disclosed herein. The covalently modified alginates are useful as a matrix for coating of any material where reduced fibrosis is desired, such as encapsulated cells for transplantation and medical devices implanted or used in the body. 6. The multiply modified alginate polymer of claim 3 , wherein{'sub': 9', '3', '2', '2', '3', '2, 'Ris methyl, —COCH, or —CH—N(CH—CH).'}12. The modified alginate polymer of claim 9 , wherein{'sub': 9', '3', '2', '2', '3', '2, 'Ris methyl, —COCH, or —CH—N(CH—CH).'}15. The modified alginate polymer of claim 1 , wherein Yand Yare hydrogen.16. A composition comprising a biological material encapsulated in an ionically crosslinked modified alginate polymer defined by .17. The composition of claim 16 , wherein the composition induces a lower foreign body response than biological material encapsulated in a similar ionically crosslinked unmodified alginate polymer.18. The composition of claim 16 , wherein the biological material is cells.19. The composition of claim 18 , wherein the cells comprise cells from xenotissue claim 18 , cells from a cadaver claim 18 , stem cells claim 18 , cells derived from stem cells claim 18 , cells from a cell line claim 18 , primary cells claim 18 , reprogrammed cells claim 18 , reprogrammed stem cells claim 18 , cells derived from reprogrammed stem cells claim 18 , genetically engineered cells claim 18 , or combinations thereof.20. The composition of claim 18 , wherein the cells are human cells.21. The composition of claim 18 , wherein the cells are insulin-producing cells.22. The composition of claim 18 , wherein the cells are pancreatic islet cells.23. The composition of claim 16 , wherein the modified alginate is further crosslinked covalently.24. The composition of claim 16 , wherein the modified alginate further comprises unmodified alginate. ...

Подробнее
24-04-2014 дата публикации

COMPOSITIONS COMPRISING HYDROGEL PARTICLES

Номер: US20140112964A1
Автор: WU XUFENG

Provided are stable compositions comprising an aqueous carrier, hydrogel particles comprising one or more polysaccharides, and one or more surfactants. Also provided are methods of making such compositions. 1. A composition comprising an aqueous carrier , hydrogel particles comprising one or more polysaccharides , and one or more surfactants , wherein said composition does not show phase separation over a period of ten days at room temperature as measured using the Phase Stability Test.2. The composition of wherein the polysaccharides are selected from the group consisting of carrageenan claim 1 , low acyl gellen gum claim 1 , low methyoxyl pectin or mixtures thereof.3. The composition of wherein the one or more polysaccharides comprise k-carrageenan.4. The composition of wherein the one or more polysaccharides comprise i-carrageenan.5. The composition of claim 1 , wherein the hydrogel particles comprise polysaccharide claim 1 , cross-linking agent and water.6. The composition of claim 5 , wherein the cross-linking agent comprises a metal salt or metal acid.7. The composition of claim 6 , wherein the cross-linking agent comprises potassium chloride claim 6 , calcium chloride claim 6 , or a mixture thereof.8. The composition of claim 7 , wherein the cross-linking agent is potassium chloride.9. The composition of wherein the composition comprises from greater than zero to 1% of the one or more polysaccharides.10. The composition of wherein the composition comprises from 0.5 to 2.5% of the cross-linking agent.11. The composition of wherein the hydrogel particles have an average particle size of from 1 micrometer (μm) to 500 μm.12. The composition of wherein the one or more surfactants are selected from the group consisting of anionic claim 1 , nonionic claim 1 , amphoteric surfactants or combinations of two or more thereof.13. The composition of wherein the one or more surfactants comprise one or more anionic surfactants.14. The composition of wherein the one or more ...

Подробнее
04-02-2016 дата публикации

COHERENT BLOOD COAGULATION STRUCTURE OF WATER-INSOLUBLE CHITOSAN AND WATER-DISPERSIBLE STARCH COATING

Номер: US20160030623A1
Автор: Drake James F.
Принадлежит:

An absorbent layer for moderating blood flow from a wound has a non-woven fabric layer of water-insoluble chitosan fibers having a coating of water-absorbent starch on at least one face of the fabric layer. The coating of water-absorbent starch penetrates into the fabric layer from a first surface over the chitosan fibers to a depth of at least 25% of the fabric layer of chitosan fibers. The chitosan fibers have average diameters of from 5 to 30 micrometers. The average weight of starch/chitosan may decrease from the first surface from which the starch has penetrated into the fabric to the depth of at least 50% of the fabric layer. The starch may be modified to include hydrophilic groups into or onto molecular chains of the starch. 1. An absorbent layer comprising a non-woven fabric layer of water-insoluble chitosan fibers having a coating of water-absorbent starch on at least one face of the fabric layer.2. The layer of wherein the coating of water-absorbent starch penetrates into the fabric layer from a first surface over the chitosan fibers to a depth of at least 25% of the fabric layer of chitosan fibers.3. The layer of wherein the chitosan fibers have average diameters of from 5 to 30 micrometers.4. The layer of wherein the chitosan fibers have average diameters of from 8 to 25 micrometers.5. The layer of wherein the chitosan fibers have average diameters of from 10 to 20 micrometers.6. The layer of wherein the chitosan fibers have average diameters of from 8 to 25 micrometers.7. The layer of wherein the coating of water-absorbent starch penetrates from a first surface into the fabric layer over the chitosan fibers to a depth of at least 50% of the fabric layer of chitosan fibers towards a second surface of the layer.8. The layer of wherein the coating of water-absorbent starch penetrates from a first surface into the fabric layer over the chitosan fibers to a depth of at least 50% of the fabric layer of chitosan fibers towards a second surface of the layer.9. ...

Подробнее
01-02-2018 дата публикации

TARGETED NANOPARTICLES

Номер: US20180028684A1
Принадлежит: nanoDERM Sciences, Inc.

The invention in the various aspects provides nanogel compositions that are safe for topical, local, and/or systemic delivery, and which can be targeted to select tissues or cells, including pathogens. In some embodiments, conjugation of antibiotics to the nanogel surface, and in particular antibiotics that disrupt outer membranes of Gram negative bacteria or antibiotics that inhibit cell wall synthesis, provide for highly effective targeting and killing of bacterial pathogens, including drug-resistant bacteria. 1. A hydrogel composition , comprising:a population of polymeric nanoparticles having conjugated to their surface polymyxin B and/or Vancomycin.2. The hydrogel composition of claim 1 , wherein the nanoparticles have polymyxin B conjugated to their surface.3. The hydrogel composition of claim 1 , wherein the nanoparticles have vancomycin conjugated to their surface.4. The hydrogel composition of claim 1 , wherein the nanoparticles have polymyxin B and vancomycin conjugated to their surface.5. The hydrogel composition of claim 1 , wherein the nanoparticles comprise cross-linked copolymers.6. The hydrogel composition of claim 5 , wherein at least one co-polymer is a polysaccharide claim 5 , which is either linear claim 5 , cyclic or branched.7. The hydrogel composition of claim 6 , wherein the polysaccharide is a glucan.8. The hydrogel composition of claim 6 , wherein the polysaccharide is at least one of dextran claim 6 , chitosan claim 6 , and cyclodextran.9. The hydrogel composition of claim 5 , wherein at least one co-polymer is selected from polyvinyl alcohol claim 5 , acrylate claim 5 , and polyacrylate.1040.-. (canceled)41. A hydrogel preparation comprising nanoparticles of dextran cross-linked with poloxamer claim 5 , and having surface conjugated antibiotic that disrupts outer membrane of gram negative bacteria claim 5 , or inhibits cell wall synthesis of gram positive or gram negative bacteria.42. The hydrogel composition of claim 41 , wherein the ...

Подробнее
31-01-2019 дата публикации

Glucose-responsive artificial muscle and manufacturing method therefor

Номер: US20190029801A1
Автор: Sachan KO, Seon Jeong Kim

The present invention relates to a glucose-reactive artificial muscle, and more particularly, to a carbon nanotube, a hydrogel-based glucose-reactive artificial muscle which has a reversible volume change due to variations in glucose concentration, a method of forming the same, a rotary artificial muscle using the same, and a method of detecting glucose. The glucose-reactive artificial muscle according to the present invention may sense variations in glucose concentration with high sensitivity within a short time by providing reversible twisting using the swelling and shrinkage of hydrogels, which occur due to a change in internal anionic charges, caused by the bonding between a boronic acid introduced to the hydrogels and glucose.

Подробнее
31-01-2019 дата публикации

METHOD FOR MANUFACTURING MICRONEEDLE BY USING BIOCOMPATIBLE POLYMER

Номер: US20190030309A1
Автор: KWON Jieun
Принадлежит:

A method of manufacturing a biocompatible polymer-based microneedle, the method comprising: (a) a primary filling step of covering, by stoppers, upper sides of multiple holes, which are formed to be spaced apart from one another, penetrate a mold, and each have a conical shape, and injecting a biocompatible polymer solution containing an appropriate amount of active ingredient by using filling needles; (b) a secondary filling step of injecting a biocompatible polymer solution containing an excipient by using the filling needles; (c) a step of solidifying the biocompatible polymer solution; and (d) a step of attaching a pad to an upper portion of the mold and then detaching the pad from the mold. The microneedle manufactured by the present invention may solve problems of degeneration of medicine, insufficient hardness, and a loss of medicine caused by a complicated process and a long manufacturing time. 1. A method of manufacturing a biocompatible polymer-based microneedle , the method comprising:(a) a primary filling step of covering, by stoppers, upper sides of multiple holes, which are formed to be spaced apart from one another, penetrate a mold, and each have a conical shape, and injecting a biocompatible polymer solution containing an appropriate amount of active ingredient by using filling needles;(b) a secondary filling step of injecting a biocompatible polymer solution containing an excipient by using the filling needles;(c) a step of solidifying the biocompatible polymer solution; and(d) a step of attaching a pad to an upper portion of the mold and then detaching the pad from the mold.2. The method according to claim 1 , wherein a vacuum is formed at lower sides of the holes while injecting the biocompatible polymer solution in the primary filling step (a).3. A method of manufacturing a biocompatible polymer-based microneedle claim 1 , the method comprising:(a) a primary filling step of positioning a pad at a lower side of a bottom of a mold having multiple ...

Подробнее
05-02-2015 дата публикации

BIO-BASED BINDERS FOR INSULATION AND NON-WOVEN MATS

Номер: US20150033981A1
Принадлежит:

An aqueous binder composition is provided that includes a carbohydrate and a crosslinking agent. In exemplary embodiments, the carbohydrate-based binder composition may also include a catalyst, a coupling agent, a process aid, a crosslinking density enhancer, an extender, a moisture resistant agent, a dedusting oil, a colorant, a corrosion inhibitor, a surfactant, a pH adjuster, and combinations thereof. The carbohydrate may be natural in origin and derived from renewable resources. Additionally, the carbohydrate polymer may have a dextrose equivalent (DE) number from 2 to 20. In at least one exemplary embodiment, the carbohydrate is a water-soluble polysaccharide such as dextrin or maltodextrin and the crosslinking agent is citric acid. Advantageously, the carbohydrates have a low viscosity and cure at moderate temperatures. The environmentally friendly, formaldehyde-free binder may be used in the formation of insulation materials and non-woven chopped strand mats. A method of making fibrous insulation products is also provided. 1. A fibrous insulation product comprising:a plurality of randomly oriented fibers; at least one carbohydrate selected from dextrin, maltodextrin, and combinations thereof having a dextrose equivalent number from 9 to 14, said at least one carbohydrate comprising from about 40% to about 95% by weight of total solids of said binder composition; and', 'at least one crosslinking agent selected from monomeric polycarboxylic acid, citric acid, or their corresponding salts, said at least one crosslinking agent comprising from about 5% to about 40% by weight of total solids of said binder composition, said at least one crosslinking agent having a molecular weight from about 90 to about 10,000; and, 'a binder composition applied to at least a portion of said fibers, said binder composition comprising the reaction product ofa surfactant comprising from about 0.01% to about 10% by weight of total solids of said binder composition.2. The fibrous ...

Подробнее
05-02-2015 дата публикации

CELLULOSE ACYLATE FILM, POLARIZING PLATE, MANUFACTURING METHOD OF POLARIZING PLATE, AND LIQUID CRYSTAL DISPLAY DEVICE

Номер: US20150033984A1
Принадлежит: FUJIFILM Corporation

There is provided a cellulose acylate film comprising a plasticizer and two or more kinds of ultraviolet absorbents specific in structure and has a moisture permeability of 1,000 to 1,700 g/m·day at a temperature of 25° C. and relative humidity of 60%, and a polarizing plate containing at least one cellulose acylate film and a liquid crystal display device containing at least one polarizing plate. 2. The cellulose acylate film as claimed in claim 1 ,wherein the film has a thickness of 15 μm to 40 μm.3. The cellulose acylate film as claimed in claim 1 ,wherein the plasticizer is a mixture of triphenyl phosphate and biphenyl phosphate.4. The cellulose acylate film as claimed in claim 1 ,wherein the plasticizer is a plasticizer which has repeating units comprising dicarboxylic acids and diols and is 700 to 10,000 in number average molecular weight.5. The cellulose acylate film as claimed in claim 4 ,wherein the plasticizer is a plasticizer formed from at least one kind of diol selected from an aliphatic diol having a carbon number of 2 to 12, an alkyl ether diol having a carbon number of 4 to 20 or an aromatic ring-containing diol having a carbon number of 6 to 20 and at least one kind of aromatic dicarboxylic acid having a carbon number in a range of 8 to 20.6. The cellulose acylate film as claimed in claim 1 ,wherein the plasticizer is a plasticizer containing a sugar ester.7. The cellulose acylate film as claimed in claim 1 , further containing a retardation raising agent.8. A polarizing plate claim 1 , containing at least one cellulose acylate film as claimed in .9. A liquid crystal display device claim 8 , containing at least one polarizing plate claimed in .10. A method of manufacturing a polarizing plate claim 1 , comprising a process in which at least one sheet of the cellulose acylate film as claimed in and a polarizer are bonded together. This is a continuation of International Application No. PCT/JP2013/062459 filed on Apr. 26, 2013, and claims priority from ...

Подробнее
04-02-2021 дата публикации

CORROSION INHIBITOR COMPOSITION AND METHODS OF INHIBITING CORROSION DURING ACID PICKLING

Номер: US20210032759A1

A corrosion inhibitor composition, which includes i) an aqueous alcohol base fluid, ii) a mixture of at least three polysaccharides selected from carboxymethyl cellulose, gum arabic, pectin, a salt of alginic acid, chitosan, dextran, hydroxyethyl cellulose, and soluble starch, with each polysaccharide that is present in the mixture being present in an amount of 0.05 to 0.5 wt. %, based on a total weight of the corrosion inhibitor composition, iii) silver nanoparticles, and iv) a pineapple leaves extract. A method of inhibiting corrosion of metal during acid cleaning/pickling whereby the metal is treated with an acidic treatment fluid containing an acid and the corrosion inhibitor composition. 1. A corrosion inhibitor composition , comprising:a base fluid comprising water and an alcohol;a mixture of at least three polysaccharides selected from the group consisting of carboxymethyl cellulose, gum arabic, pectin, a salt of alginic acid, chitosan, dextran, hydroxyethyl cellulose, and soluble starch, with each polysaccharide that is present in the mixture being present in an amount of 0.05 to 0.5 wt. %, based on a total weight of the corrosion inhibitor composition;silver nanoparticles; anda pineapple leaves extract.2. The corrosion inhibitor composition of claim 1 , wherein the alcohol is a monoalcohol.3. The corrosion inhibitor composition of claim 1 , wherein the alcohol is isopropanol.4. The corrosion inhibitor composition of claim 1 , wherein a ratio of water to the alcohol by volume is 2:1 to 1:2.5. The corrosion inhibitor composition of claim 1 , wherein three polysaccharides are present in the mixture.6. The corrosion inhibitor composition of claim 5 , wherein each of the three polysaccharides is present in an amount of 30 to 40 wt. % claim 5 , based on a total weight of the mixture.7. The corrosion inhibitor composition of claim 1 , wherein the mixture consists of carboxymethyl cellulose claim 1 , gum arabic claim 1 , and pectin.8. The corrosion inhibitor ...

Подробнее
30-01-2020 дата публикации

CONTACT LENS WITH A HYDROPHILIC LAYER

Номер: US20200033636A1
Принадлежит:

Embodiments of the technology relate to a contact lens having a core that is covalently coated by a hydrogel layer, and to methods of making such a lens. In one aspect, embodiments provide for a coated contact lens comprising a lens core comprising an outer surface; and a hydrogel layer covalently attached to at least a portion of the outer surface, the hydrogel layer adapted to contact an ophthalmic surface, wherein the hydrogel layer comprises a hydrophilic polymer population having a first PEG species and a second PEG species, the first PEG species being at least partially cross-linked to the second PEG species. 2. The coated contact lens of claim 1 , wherein the second polymer species is polyacrylamide.3. The coated contact lens of claim 1 , wherein the hydrogel layer is covalently attached to the core by a sulfonyl moiety claim 1 , a thioether moiety claim 1 , an amine moiety claim 1 , or any combination thereof.4. The coated contact lens of claim 1 , wherein the hydrogel layer comprises a thickness between 0.01 microns and 0.05 microns.5. The coated contact lens of claim 1 , wherein one or more of the polyethylene glycol and the second polymer species is a branched species having a branch count between two to twelve branch arms.6. The coated contact lens of claim 1 , wherein one or more of the polyethylene glycol and the second polymer species comprises starred branching.7. The coated contact lens of claim 1 , wherein the coated contact lens is characterized as comprising an advancing contact angle between 20 degrees to 50 degrees.8. The coated contact lens of claim 1 , wherein the coated contact lens is characterized as comprising an advancing contact angle between 25 degrees to 35 degrees.9. The coated contact lens of claim 1 , wherein the hydrogel layer comprises between 80% to 98% water by weight.11. The coated contact lens of claim 10 , wherein the second polymer species comprises a second polyacrylamide species.12. The coated contact lens of claim 10 , ...

Подробнее
08-02-2018 дата публикации

BIOSOURCED POLYMER FOR MANUFACTURING, VIA CATALYTIC CARBONATION, A NON-BITUMINOUS POLYHYDROXYURETHANE BINDER FOR ROADWAY OR CIVIL ENGINEERING-RELATED USES

Номер: US20180037673A1
Принадлежит:

The invention relates to a biosourced polymer obtained by dual chemical functionalization of chitosan, usable for catalytic carbonation of cyclic ethers by means of carbon dioxide, and a binder composition for creating layers and/or coatings for road construction and/or civil engineering, marking materials, or sealing or insulation materials. Said composition contains a polyhydroxyurethane polymer binder resulting from the reaction of at least one polyamine with at least one polycyclocarbonate. Said polycyclocarbonate was obtained by carbonating a (cyclic) poly(ether) with carbon dioxide catalyzed by said biosourced polymer. 115-. (canceled)17. Biosourced polymer according to claim 16 , wherein GA is the carboxylate group.18. Biosourced polymer according to claim 16 , wherein GC is a quaternary ammonium group.20. Biosourced polymer according to claim 16 , wherein M represents K and X represents I.21. Binder composition for making road construction and/or civil engineering layers and/or coatings claim 16 , marking products claim 16 , or sealants or insulating products claim 16 , comprising a polymer binder of polyhydroxyurethane nature claim 16 , derived from the reaction of at least one polyamine with at least one polycyclocarbonate claim 16 , wherein the polycyclocarbonate was obtained by carbonation of a poly(cyclic ether) with carbon dioxide catalyzed by a biosourced polymer according to .22. Binder composition according to claim 21 , wherein the poly(cyclic ether) is a poly(epoxide).23. Binder composition according to claim 22 , wherein the poly(cyclic ether) is a diepoxide.24. Binder composition according to claim 21 , wherein the polyamine is a diamine and the polycyclocarbonate is a dicyclocarbonate.25. Binder composition according to claim 21 , wherein the cyclocarbonate groups of the polycyclocarbonate are a 5 or 6-membered ring.26. Binder composition according to claim 21 , wherein the polyhydroxyurethane was formed without using isocyanate reagents.27. ...

Подробнее
08-02-2018 дата публикации

Fire-Retardant Compositions and Their Uses

Номер: US20180037998A1
Принадлежит:

Disclosed are fire-retardant concentrates and solutions comprising mixtures of ammonium phosphates. In certain embodiments, less of the concentrate is needed to form an effective fire-retardant solution. In certain embodiments, the fire-retardant solutions exhibit decreased corrosion, especially with regard to magnesium. In certain embodiments, the fire-retardant solutions exhibit decreased aquatic toxicity. 1. A fire-retardant concentrate composition comprising a mixture of ammonium phosphates and a corrosion inhibitor system that comprises at least one biopolymer , wherein the mixture of ammonium phosphates has a molar ratio of ammoniacal nitrogen to phosphorus (N/P molar ratio) in a range of from about 1.1 to about 1.9.2. The fire-retardant concentrate composition of claim 1 , wherein the N/P molar ratio is from about 1.35 to about 1.65.3. The fire-retardant concentrate composition of claim 1 , wherein the N/P molar ratio is from about 1.4 to about 1.6.4. The fire-retardant concentrate composition of claim 1 , wherein the amount of ammonium phosphate in the fire-retardant concentrate is from about 75% to about 97% by weight of the total concentrate composition.5. The fire-retardant concentrate composition of claim 1 , wherein the ammonium phosphates comprise a mixture of at least two ammonium phosphates selected from the group consisting of ammonium orthophosphates claim 1 , ammonium pyrophosphates claim 1 , and ammonium polyphosphates having an average chain length of less than 20 phosphorus atoms.6. The fire-retardant concentrate composition of claim 5 , comprising at least two ammonium orthophosphates or at least two ammonium pyrophosphates.7. The fire-retardant concentrate composition of claim 5 , comprising at least one ammonium orthophosphate and at least one ammonium pyrophosphate.8. The fire-retardant concentrate composition of claim 1 , wherein the mixture of ammonium phosphates comprises monoammonium orthophosphate (MAP) and diammonium orthophosphate ( ...

Подробнее
24-02-2022 дата публикации

SPRAYABLE POLYMERS AS ADHESION BARRIERS

Номер: US20220054403A1
Принадлежит:

A formulation for generating an adhesion barrier that includes a plurality of particles or a dry powder that is made of a polymer combination of at least one biodegradable polymer and at least one water soluble polymer is disclosed. Methods of making and delivering the formulation are further disclosed. The formulation of particles is deposited on a surface of internal body tissue and the deposited formulation absorbs moisture from the tissue and forms a film over the surface. The film acts as an adhesion barrier by reducing or preventing adhesion of the surface to other body tissue. 127-. (canceled)29. The formulation of claim 28 , wherein the particles swell and overlap when the particles absorb moisture claim 28 , wherein the swelling and overlap facilitates the formation of the film that reduces or prevents the adhesion.30. The formulation of claim 28 , wherein the plurality of particles is uniformly suspended in a liquid claim 28 , wherein the liquid has a boiling point below 0° C.31. The formulation of claim 28 , wherein when exposed to moisture claim 28 , the particles absorb between 1 to 80 wt % water.32. The formulation of claim 28 , wherein the film loses strength at a time between 30-60 days after the absorption of the moisture.33. The formulation of claim 28 , further comprising a therapeutic agent selected from the group consisting of an anti-inflammatory claim 28 , anti-infective claim 28 , hemostatic claim 28 , chemotherapeutic claim 28 , and any combination thereof.34. The formulation of claim 33 , wherein the anti-inflammatory agent is a corticosteroid.35. The formulation of claim 28 , wherein the particles comprise PLGA claim 28 , wherein the ratio of L-lactide to glycolide in the PLGA is from 10/90 to 85/15.36. The formulation of claim 28 , whereinthe PLGA is between about 10% to about 90% and the alginate is between about 10% to about 90%,the PLGA is between about 10% to about 90% and the PVP is between about 10% to about 90%,the PLGA is between ...

Подробнее
07-02-2019 дата публикации

NATURAL POLYMER BASED TISSUE ADHESIVE WITH HEALING PROMOTING PROPERTIES

Номер: US20190038798A1
Принадлежит:

A tissue adhesive with healing promotion properties formed from a mixture of natural polymers and an activating agent that enhances the adhesive properties of the natural polymer mixture is described. Use of an activating agent and a combination of the natural polymers is unique. The natural polymer tissue adhesive may be useful as a post-operative application for tonsillectomy or adenoidectomy surgery, as an internal tissue adhesive for surgery or wound repair or for application to a burn or skin donor site. For internal use, an optional treatment to improve resistance of the activated adhesive to body fluids is also described. The adhesive described not only functions as an adhesive but would also serve as a protective barrier when applied to surgery or skin sites. In addition, the natural polymers would promote healing due to the inherent properties of the polymers selected. 1. A tissue adhesive suitable for skin contact or internal use comprisinga. a mixture of natural polymers andb. an activating agent enhancing the adhesive properties of the natural properties of the natural polymer mixture;this tissue adhesive formulation is particularly useful as a protective, enhanced healing device on the surgical site created during tonsillectomy or adenoidal surgery, as an internal tissue adhesive as a replacement for sutures or staples or as a protective, enhanced healing device for burns, skin grafts or skin donor sites;2. The adhesive material described in where the natural polymers are selected from polysaccharides or partial hydrolysis derivatives or neutralization salts thereof;3. The adhesive material described in where the natural polymers selected are chitosan and an alginate;4. The method of where the natural polymers are chitosan and sodium alginate;5. The adhesive material described in where the activating agent is a dilute aqueous solution of an acid;6. The method of where the acid solution is that of a carboxylic acid;7. The method of where the carboxylic ...

Подробнее